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CHAPTER 1
IRON CHAPERONES FOR MITOCHONDRIAL FE-S CLUSTER BIOSYNTHESIS AND
FERRITIN IRON STORAGE
1.0 Prelude
Iron is essential for life and is utilized for a variety of biological processes. It serves as a
cofactor for many proteins including ribonucleotide reductase, an enzyme central to DNA
production, and hemoglobin, which allows for the transport and delivery of molecular
oxygen throughout the body.

At high concentrations, iron has toxic effects due to its

chemical reaction with molecular oxygen that can generate hydroxyl radicals that damage
DNA and proteins. In humans, accumulation of excess cellular iron results in cirrhosis,
arthritis, cardiomyopathy and diabetes mellitus, and is associated with an increased risk of
cancer and heart disease. Excess iron accumulation is also associated with several
inherited disorders such as neuroferritinopathy and Huntington’s disease, as well as
common neurodegenerative disorders such as Friedreich’s Ataxia, Parkinson’s and
Alzheimer’s disease. In contrast, decreased brain iron content due to prenatal or postnatal
iron deficiency can result in permanent neurocognitive and motor impairment. Worldwide,
iron deficiency is the most common and widespread nutritional disorder affecting 2 billion
people. The Iron Disorders Institute estimates conservatively that one-third of the world’s
population has or is at risk of experiencing Iron-Out-of-Balance in his or her lifetime. It is
clear therefore that intracellular iron content must be maintained within a narrow range to
avoid the adverse effects of iron depletion or excess. Ferritin, the central iron storage
protein in the body, helps maintain this iron balance. While the mechanism of ferritin iron
loading is unclear, recently the Poly r(C)-Binding Protein (PCBP) family was identified as
possible iron chaperones. Therefore, PCBP family members are essential for regulation of
cellular iron homeostasis and a molecular understanding of their mechanism is required in
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order to gain a better understanding of iron storage and utilization events essential to
human life. The central theme of my research, therefore, has been to characterize the
functional and biophysical properties of the PCBPs to provide a basis for exploring new
strategies to help control iron regulation in human patients that lack functional iron
homeostasis.
This first chapter of my dissertation serves as an introduction to iron regulation in the
body and discusses the disorders caused by iron excess or deficiency. There are many
pathways that regulate cellular iron homeostasis. Two of the major pathways, namely, the
Fe-S cluster biogenesis pathway and the Ferritin pathway have been described in detail
here. This chapter serves as the relevant background material for the following chapters in
this dissertation, which discuss the role of the PCBPs in maintaining metal homeostasis in
the cell. This work has been published as a review article of which the author of this
dissertation is the primary author. The reference for the published article is as follows:
Subramanian, P., Rodrigues, A.V., Ghimire-Rijal, S., and Stemmler, T.L. “Iron chaperones
for mitochondrial Fe-S cluster biosynthesis and ferritin iron storage” Curr. Opin. Chem. Biol.,
2011, 15(2): 312-318.
1.1 Abstract
Protein controlled iron homeostasis is essential for maintaining appropriate levels and
availability of metal within cells. Recently, two iron chaperones have been discovered that
direct metal within two unique pathways: (1) mitochondrial iron–sulfur (Fe–S) cluster
assembly and (2) within the ferritin iron storage system. Although structural and functional
details describing how these iron chaperones operate are emerging, both share similar iron
binding affinities and metal–ligand site structures that enable them to bind and release Fe2+
to specific protein partners. Molecular details related to iron binding and delivery by these
chaperones will be explored within this review.
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1.2 Introduction
Iron is essential for life and its unique chemical characteristics are often exploited in
nature to assist cells in performing inherently complex oxidation chemistry, promote oxygen
transport/storage and drive electron transfer pathways [1]. Iron is typically absorbed into the
body through diet [2] and on an average, humans absorb 1–2 mg of iron from diet each day
[3]. Although the amount of iron abstracted from the diet is low, tight regulation of absorbed
iron is critical, as humans have no physiologic pathway to excrete metal. Once consumed,
over 60% of the iron is incorporated into hemoglobin through developing erythroid
precursors and finally into mature red blood cells. The second and third possible fates for
Fe include being directed towards the iron storage protein ferritin or being transferred
throughout the body for incorporation into metalloprotein iron cofactor sites. As a cofactor,
Fe is often found associated within iron–sulfur (Fe–S) clusters, found as mononuclear Fe–
S, 2Fe–2S, 4Fe–4S and other higher nuclearity clusters common to nature [4]. Given the
body’s need to absorb and maintain appropriate iron levels, Fe reuse and recycling from
degraded sources is another method the body uses to maintain iron homeostasis. A simple
breakdown in any of these pathways can lead to conditions that are detrimental to human
health.
When maintained at balanced levels, iron is essential for cellular and organism viability,
however excess is toxic and deficiency leads to a variety of physiological and
developmental irregularities [3]. Disorders related to a breakdown in iron homeostasis are
among the most common human diseases. Diseases of iron overload are highly prevalent,
with the hepatological disorder hereditary hemochromatosis being one of the most common
[5]. Hemochromatosis patients absorb two to three times more iron than normal dietary iron
levels. Excess iron is often deposited in the liver and redox chemistry performed by
unregulated metal can kill the cell/organism. Neuronal iron accumulation is a phenotype of
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numerous neurodegenerative disorders (Parkinson’s disease, Alzheimer’s disease,
Friedreich’s ataxia, etc.). In these disorders, unregulated but redox active metal is pooled
within specific regions of the brain generating oxidative stress through iron produced
reactive oxygen species (ROS) formation [6]. ROS can damage membrane phospholipids
and generate reactive aldehydes that damage proteins, leading to the accumulation of
misfolded protein aggregates. Although examples of the toxic effects of iron overload are
prevalent, iron deficiency is an even larger human health issue affecting billions [7]. While
iron deficiency leads to decreased cognitive development in children [8], continual long-term
deficiency leads to numerous other health related issues [3]. It is clear that biological
pathways controlling iron reactivity are essential, however it is equally clear that pathways
ensuring metal delivery are equally important for maintaining cell viability. Many pathways
that regulate cellular iron homeostasis are controlled at the genetic and at the protein level
[9,10]. As outlined in the transferrin cycle, iron is imported through endocytosis of Fe3+
loaded transferrin (Tf) interacting with the transferrin receptor (Tf-R), in a tightly regulated
feedback loop controlled at the genetic and protein level (Figure 1.1).
In eukaryotes, iron can be diverted to the mitochondria where it can be utilized during
heme production or during Fe–S cluster assembly (pathway #1 in Figure 1.1). During
mitochondrial Fe–S cluster assembly, the ISC machinery proteins work together to form
clusters that can be loaded onto apo-mitochondrial proteins or pumped out of the
mitochondria in some manner (labeled X) to be used by the cytosolic Fe–S cluster
assembly machinery (CIA). Cytosolic iron can also be directed for storage into ferritin in an
inert form for future use (pathway #2 in Figure 1.1). Although there are obviously other fates
for cellular iron, recently two iron chaperones have been discovered that control iron
delivery in the pathways highlighted above. An overview of the structure and biophysical
properties leading to iron binding by these two chaperones is the basis of this review.
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Figure 1.1 Major pathways for iron incorporation/utilization within a cell. Two
pathways for Fe2+ utilization highlighted within the review include: (1) frataxin and its role in
mitochondrial Fe–S cluster assembly via the ISC-machinery (* including the cysteine
desulfurase/Isd11 complex that provides sulfur); (2) PCBP and its role in ferritin associated
iron storage.
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1.3 Fe-S cluster biosynthesis iron chaperones
In eukaryotes, the mitochondrial ISC assembly is the major pathway for Fe–S cluster
production. Key players in the yeast ISC machinery include the assembly scaffold protein
(either Isu1 or 2, for clarity we will refer to only Isu1), the cysteine desulfurase (Nfs1) that
provides sulfur to Isu1, the accessory protein (Isd11) that works in complex with Nfs1,
ferredoxin (Yah1) working with a ferredoxin reductase (Arh1) to provide electrons for the
reaction, and the putative iron chaperone protein frataxin (Yfh1) [11]. Protein orthologs are
highly conserved and found in all eukaryotes, while in prokaryotes most are found within the
ISC pathway while variants of these proteins exist within the sulfur mobilization (SUF) and
the nitrogen fixation (NIF) assembly pathways [12]. Isu1 is one of the most conserved
proteins [13,14], containing three conserved cysteines critical for de novo Fe-S cluster
assembly [15••,16•]. Sulfur transfer between Nfs1 and Isu1 occurs as a persulfide (–SSH)
through a direct interaction between partners [17]; insight into the nature of this interaction
has come from a recent structural characterization of bacterial orthologs [18••]. In in vivo,
Yfh1 is essential for Fe–S cluster maturation [19••], and an interaction between Yfh1 and
Isu1/Nfs1/Isd11 is critical for cluster biosynthesis [20]. In in vitro, frataxin was shown to
deliver iron to the scaffold protein to stimulate Fe–S cluster assembly [21••]. On the basis of
these and additional reports (see review [11]), frataxin was shown to play a direct role in
mitochondrial Fe–S cluster assembly, possibly by serving as the iron chaperone [20,22],
deficiency of which has direct consequences regarding cellular oxidative stress [23].
Insight into frataxin’s function has come from investigating the structure and iron
binding abilities of numerous orthologs [24•]. Frataxin is a member of the α–β sandwich
motif family, with N-terminal and C-terminal helices constructing one molecular plane and
the second constructed by at least five anti-parallel β-strands [25–30]. Key structural
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features for the frataxin orthologs include highly conserved surface exposed acidic residues
lining the helix-1/strand-1 junction, a short predominately unstructured N-terminal region in
eukaryotic orthologs only, and a C-terminal region in the human and bacterial proteins that
confer stability [31]. The iron binding ability of frataxin was first identified in the yeast
ortholog associated with iron induced aggregation stabilized by low salt/oxygenated solution
conditions [32]. Monomeric bacterial, yeast, fly and human frataxin have since been shown
to bind iron with micromolar affinity [21••,28,33–36], and in vivo mutations preventing Yfh1
aggregation show no Fe–S cluster phenotypes under normal growth conditions [37],
indicating while protein aggregation may be important under oxidative stress, monomeric
frataxin is active during Fe–S cluster assembly. Experimental data verify conserved acidic
residues on frataxin’s helix-1/strand-1 junction are directly involved in iron binding
[28,33,35]. Structural studies confirm monomeric frataxin binds high spin Fe2+ in a
symmetric 6-coordinate ligand environment constructed of only oxygen and nitrogen
ligands, in agreement with the conserved acidic residues identified by NMR as iron ligands
[35,36,38]. These data suggest as a starting point for iron delivery, frataxin binds iron using
carboxylate side chain oxygens from conserved Asp and Glu residues from the helix-1/
strand-1 iron binding sites, most likely with assistance from water molecules. Binding in this
manner would predispose iron for delivery to Isu1 (Figure 1.2) since the exposed metal
would be positioned for delivery to the protein partner and the charged surface surrounding
the metal would be amenable for forming an interaction with a complementary charged
region of the protein partner. Yfh1 undergoes an iron-stimulated interaction with Isu1/Nfs1
[20,39,40] in agreement with frataxin interacting directly with members of the ISC assembly
machinery.
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Figure 1.2 Model for iron binding sites on Yfh1 and Isu1. Molecular details of the 2 Fe2+
binding sites on Yfh1 (PDB #2GA5), and the Cys rich active site on Isu1 (modeled structure)
coupled with possible Isu1 Fe2+ binding sites on the protein’s C-terminus. Ferrous iron (blue
dots) shown with arrow denoting Fe transfer events between the two proteins
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In vivo mutational studies place frataxin’s acidic helix-1/strand-1 ridge, with residues on
the Yfh1 β-sheet surface, as interacting with Isu1 [39–43]. In vitro binding interactions show
frataxin/ scaffold binding is iron dependent and occurs at nM binding affinity [36, 44, and
45]. Chemical shift mapping studies provide spectroscopic confirmation that Isu1 interacts
with Yfh1 on frataxin’s acidic helix-1/strand-1 ridge utilizing the protein’s β-sheet surface, in
close agreement with in vivo mutational analysis [45]. In eukaryotic systems, activity assays
for Fe-S cluster production confirm iron loaded frataxin stimulates in vitro Fe–S cluster
assembly, possibly by delivering the Fe2+ required for cluster production [21••,36,46]. Direct
structural details of the frataxin/scaffold interaction are however lacking. Two recent
structural papers shed light on the potential binding interaction between these protein
partners. Crystallographic data on the Aquifex aeolicus IscU ortholog, with cluster bound,
confirm the three conserved Cys residues implicated in assembly form the active site of
IscU [47]. An even more exciting result comes from the structure of the bacterial cysteine
desulfurase (IscS) in complex with IscU [18••]. This structure shows IscU binds to IscS such
that the IscU Cys active site is in close contact with the IscS Cys residue implicated in
forming the persulfide used for sulfur transfer. Binding of Isu1 to Nfs1 in this manner would
prevent frataxin from interacting in this region, assuming sulfur delivery happens before iron
delivery. Irrespective of this assumption, mounting evidence suggests all proteins in the ISC
machinery form a complex that promotes the formation of a stable macromolecular complex
used to accomplish cluster assembly, so the frataxin piece of this puzzle would need to fit in
a unique location on Isu1. A likely candidate for where Yfh1 could bind to Isu1 is on the
scaffold protein’s C-terminal helix (Figure 1.2) [45]. The charge distribution from the
electrostatic potential surface of Isu1 in this region matches nicely to the Yfh1 β-sheet
surface. Conserved acidic/basic residues on Isu1’s C-terminal helix could serve as the initial
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Fe2+ binding residues, metal could then translocate to the scaffold’s active site [45].
Positional orientation of bacterial frataxin on the IscS/U from small angle X-ray scattering
studies [48] suggests that such an orientation may be possible, although this orientation is
likely to be altered between the prokaryotic and eukaryotic orthologs since the accessory
protein Isd11 found only in eukaryotes is likely also positioned in this region. Following Fe
delivery to Isu1 by Yfh1, the binding energetics are reduced, frataxin dissociates from its
partner and Isu1 is primed for delivery of the second Fe atom required to make a 2Fe–2S
cluster.
Recently it has been suggested frataxin may participate in Fe-S cluster biosynthesis by
regulating activity of the cysteine desulfurase. NMR mapping studies of bacterial frataxin
(CyaY) onto the bacterial IscS suggest residues lining frataxin’s β-sheet ridge tangential to
the C-terminus of helix 1, with helix-1 residues, participate in IscS binding [49]. Mutagenesis
and binding studies implicate a region on one IscS monomer, in proximity to the persulfide
site in the second molecule in the dimer, as the CyaY binding surface on IscS [18••]. Recent
studies suggest CyaY acts as an iron-dependent inhibitor of cluster formation by negatively
regulating IscS activity [49]. In contrast, another recent report suggests human frataxin acts
as an allosteric activator of Nfs1 [50]. Regardless, binding of frataxin to the ISC machinery
is important during assembly and it will be interesting to see how this binding is finally
correlated to iron delivery and assembly.
1.4 Ferritin iron chaperones
Cellular pathways directing iron storage are essential for preventing iron toxicity during
overload and ensuring availability during deficiency. Storage is directed by the 4-helix
bundle protein ferritin [51]. Mammalian cytoplasmic ferritins exist as a 24 subunits multimer
of 2 ferritin subunits: H chain (21,000 kDa), which controls the ferroxidase chemistry
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coupled to iron storage, and the L chain (19,000 kDa) which provides the iron entry ports
and stabilizes the protein. Apo-ferritin H and L chains self-assemble to form a spherical
protein shell that stores up to 4500 iron atoms as ferroxyhydrite within the central cavity.
Iron storage involves two key steps: iron oxidation, leading to the formation of a µoxo(hydroxo)-bridged di-Fe(III) intermediate, and mineralization, depositing the intermediate
as inert ferrihydrite mineral. To proceed, iron must first be delivered to ferritin, and ferrous
iron delivery occurs at a ferritin oligomer hydrophilic threefold (iron entry) channel. H-chain
surface exposed residues H118 [52] and C130 [53], with threefold channel funnel like
forming residues Asp131 and Glu134 [54], are used during iron import. Binding of an iron
chaperone must therefore proceed through direct contact with ferritin’s threefold iron entry
site (see Figure 1.3).
Recently, the human poly (rC)-binding protein (PCBP) was shown to function as a
cytosolic iron chaperone that delivers Fe2+ to ferritin [55••]. The RNA-binding PCBP protein
family was originally shown to be important in mRNA stabilization and translational
activation/silencing [56]. PCBPs have 3 KH (hnRNP K homology) domains, with structures
of the two N-terminal domains and the third domain of PCBP2 being characterized [57,58].
Expression of human PCBP1 recovered an iron loading deficiency for human ferritin
expressed in yeast [55]. PCBP1 binds to ferritin in vivo and in vitro facilitates iron loading.
PCBP1 binds 3 iron atoms at µM binding affinity comparable to frataxin’s iron affinity [24•].
Metal binding sites on PCBP are unknown; however, recent iron structural data indicate
PCBP1/2 bind ferrous iron in a 6-coordinate oxygen/nitrogen ligand environment (chapter 2
of this dissertation). Although molecular details of PCBP as an iron chaperone are still
emerging, it is interesting to note that thermodynamic and structural data regarding PCBP
iron binding are so similar to that of the Fe–S assembly iron chaperone.

12

Figure 1.3 Structural details of PCBP’s as a ferritin iron chaperone. Top right: PCBP2
total projected structure based on domains 1 and 2 (PDB #2JZX) and domain 3 (PDB
#2P2R) structure linked together for visual clarity associated with 3 bound iron atoms (blue
dots). Top left: structure of the human ferritin 24-mer (PDB #3AJO) with iron loaded (blue
dot) trimeric symmetry center. Bottom left: expansion of the ferritin trimeric interface with
residues from three subunits involved in Fe2+ loading (H118 and C130). In addition,
residues (D131 and E134) on the inner side of the iron incorporation gate that support
metal exchange are also given.
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1.5 Conclusions
Evidence that frataxin and PCBP are iron chaperones is compelling, although
clarification of their function at the genetic, molecular and atomic levels will be important for
understanding how they operate. There are still many questions that remain regarding the
identity of other chaperones, how iron is loaded onto a chaperone and what promotes
chaperone metal specificity? A possible candidate for the first question is the Glutaredoxins
Grx3/4, members of the thioredoxin (Trx) fold family. Grx3/4 are central for cellular iron
trafficking and a strong dependence of iron binding for Grx3/4 on core components in the
ISC pathway indicate Grx3/4 bind iron as a Fe–S cluster [59]. The ability to form a bridging
2Fe–2S cluster with Fra1/2 for activation of Aft1 [60], coupled with the direct dependence of
Grx3/4 on iron loading into heme, Fe–S clusters, into ribonucleotide reductase, etc.
suggests iron activated by Grx3/4 may be utilized by other dedicated assembly factors [59].
Frataxin and PCBP are most likely the start of a soon to be recognized long list of iron
chaperones.
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CHAPTER 2
BIOPHYSICAL CHARACTERIZATION OF THE FERRITIN IRON CHAPERONE
PROTEINS, PCBP1 AND PCBP2
2.0 Prelude
Ferritin’s capacity to store iron is essential for life in mammals, as it helps maintain an
iron balance (1, 2). Although ferritin has been studied for over 50 years, the mechanism by
which cytosolic iron is delivered to ferritin has until recently been unknown. The central
hypothesis of this chapter is that the proteins PCBP1 and PCBP2 serve as iron chaperones
for different tissue specific ferritins and additional pathways that require iron. The objective
in this study is to characterize the molecular details for the interaction between PCBP1 (as
well as the family member PCBP2), iron and ferritin using a combination of biophysical
techniques. This work is currently under preparation for publication and will be submitted for
peer review to the journal Biochemistry. The author of this dissertation is the primary author
of this paper which will have the following reference: Poorna Subramanian, Sudipa GhimireRijal, Ruth A. Sinnamon, Sebastien Leidgens, Mrinmoy Chakrabarti, Caroline C. Philpott,
Paul A. Lindahl, and Timothy L. Stemmler. “Biophysical characterization of the ferritin iron
chaperone proteins PCBP1 and PCBP2”. Biochemistry, 2013.
2.1 Abstract
The Poly Cytosine Binding Protein (PCBP) family was recently shown to be essential
for regulation of cellular iron homeostasis, with two family members, PCBP1 and PCBP2,
shown to act as cytosolic iron chaperones (3). In this paper, we present a biophysical
characterization of the iron binding and metal delivery properties of PCBP1 and PCBP2 as
a starting point for understanding their metal regulation activities. Both proteins are well
folded with a predominantly helical structural content, as confirmed by Circular Dichroism
spectroscopy.

Isothermal Titration Calorimetry measurements show both proteins bind
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ferrous iron with micromolar binding affinity in an exothermically driven process, values
typical of other putative iron chaperones. Ferrous iron is coordinated to PCBP1 and 2 by
five or six O/N ligands, confirmed by X-ray Absorption Spectroscopy (XAS). Mössbauer
spectroscopy indicates that bound ferrous iron exists in multiple metal binding sites on the
protein. Our data not only validate that PCBP family members are iron binding proteins, but
they strengthen the concept of an iron chaperone role for these proteins within the cellular
iron homeostasis pathway.
2.2 Introduction
Iron is indispensible for cell viability. Given the versatility in chemical reactivity provided
by the metal, it is no surprise that iron is utilized in nearly every biological pathway in every
cell type (4). Given the diverse reactivity of the metal and its essential role in life, there is a
large amount of cellular effort directed at maintaining iron homeostasis. Nutritional
deficiency starves cells of an element that is required for life while overabundance is equally
harmful as unregulated Fe(II) can react with molecular oxygen to produce reactive oxygen
based species that destroy cellular DNA and compromise cellular efficacy (5). Control of
cellular iron homeostasis is therefore essential for cell (and organism) viability. Iron
deficiency and overload are linked to several human disorders for example Anemia and
Hemochromatosis, respectively (4). Numerous reports suggest iron stores are closely linked
to the incidence of heart attack and coronary artery disease. Heart failure, specifically
cardiomyopathy, is a major cause of death in patients with iron overload from the
thalassemias and in patients with the cardio- and neurodegenerative disorder Friedreich's
Ataxia (4, 6, 7). As a result, intracellular iron content and metal reactivity is maintained
within a narrow range to avoid the adverse effects of iron depletion or excess. A major
player in regulating iron storage and metal availability/reactivity in the body is the
multiprotein complex ferritin (2). However, it has recently been shown that members of the
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human Poly r(C)-Binding Protein family direct metal shuttling to ferritin and to cytosolic Fe
metalloproteins, possibly by serving as iron chaperones in the loading pathways (3).
Until recently, the identity of the protein responsible for delivering metal to ferritin has
been unknown. In humans, ferritin is a 24-mer protein ensemble that helps direct cellular
iron homeostasis by releasing or storing iron depending on the body’s metal levels (8). A
single ferritin multimer can store up to 4500 iron atoms in the center of its spherical shell as
inert ferrihydrite (9). In a recent report, the human Poly r(C)-Binding Protein 1 (PCBP1) was
identified as a cellular factor that promoted human ferritin iron loading when coexpressed in
yeast cells.

PCBP1 is an iron binding protein itself with a mM metal binding affinity.

Coimmunoprecipitation studies in the presence of iron showed a direct in vivo interaction
between ferritin and PCBP1. At the cellular level, depletion of PCBP1 in human cells
inhibited ferritin iron loading and increased cytosolic iron pools (3). These data implicate
PCBP as required for ferritin iron loading and suggest the protein is serving as an iron
chaperone that delivers metal to ferritin for storage.
To better understand the role of the PCBPs in ferritin iron loading and to provide
mechanistic details of metal transfer between protein partners, we performed a
comprehensive characterization of the metal binding properties of two PCBP family
members (PCBP1 and PCBP2).

Experiments were performed specifically to provide a

basic characterization of the biophysical properties of PCBP1 and PCBP2 before metal
loading and to characterize the metal binding ability, structure and electronic properties of
metal bound to the protein. Characterization included using mass spectrometry to confirm
the molecular weight of the proteins, size exclusion chromatography to obtain the protein
oligomeric state and circular dichroism experiments to compare the secondary structure of
the two proteins. Metal binding characteristics were investigated using isothermal titration
calorimetry (ITC), X-ray absorption spectroscopy (XAS) and Mossbauer spectroscopy

24
techniques. Combined, these studies help clarify the molecular picture of how the PCBP’s
can participate in metal transfer to ferritin.
2.3 Experimental Methods
2.3.1 Protein Expression and purification
PCBP1 purification was described earlier (10) and is outlined briefly below. Human
PCBP1 was cloned into a pCDF-sumo fusion construct vector (courtesy of Dr. Zhe Yang)
and transformed into BL21∗ Escherichia coli competent cells containing streptomycin
resistance. Cells were grown in 1L TB media at 37°C to an OD600 of 1.2, induced with a
IPTG concentration of 0.1 mM and then grown for 22 h at 15°C. Cells were collected,
resuspended in 50 ml of buffer A (20 mM Tris [pH 7.9], 250 mM NaCl, 30 mM imidazole,
20% glycerol, and 2.5 mM TCEP) with an EDTA-free protease inhibitor cocktail tablet
(Roche), 30 mgs of lysozyme, and were broken using a French Press. The extract was
spun at 21,000 rpm for 30 min and loaded on a nickel column. Separation was carried out
using a gradient between buffer A and buffer B (20mM Tris [pH 7.9], 250 mM NaCl, 500 mM
imidazole, 20% glycerol, 2.5 mM TCEP), with the protein eluting at 110–230 mM imidazole.
The sumo tag was cleaved by adding 1/1000 concentration sumo protease and incubating
overnight at 4°C. Protein was buffer exchanged with buffer A before passing on the nickel
column again to separate the tag from the untagged protein. The protein was run on a S200 gel filtration column (GE Healthcare) and it eluted out at a molecular weight of ∼75 kDa,
consistent with the dimeric form of the protein.
Human PCBP2 cDNA was cloned into pTYB11 vector from NEB resulting in a fusion
construct of PCBP2+intein tag. The vector was transformed into BL21∗ Escherichia coli
competent cells. 1L TB media was inoculated with a 10 ml overnight starter culture and 100
µg/ml of ampicillin. The culture was grown by shaking at 250 rpm at 37 °C, until an OD600 of
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~1.2 was reached and then induced with 0.4 mM IPTG. After induction, the culture was
shaken at 16 °C for 20-22 h. Cells were harvested by centrifugation for 10 min at 7000 rpm
and re-suspended in buffer C (20 mM Tris [pH 8.5], 500 mM NaCl, 5 mL/g cells) in the
presence of complete EDTA free Protease Inhibitor Cocktail (Roche), 1% Triton X-100 (BioRad) and 0.1 mM TCEP [tris-(2 Cyanoethyl)phosphine]. The resuspended solution was
lysed by two passes of french press and the clarified lysate was obtained by centrifugation
at high speed (21000 rpm) for 45 mins. The crude soluble extract was filtered using a 0.22
µm filter and loaded onto chitin beads (NEB). The beads were washed with 20 column
volumes of buffer C to remove any unbound protein impurities. All buffers were purged with
argon for one hour before use on the column. Self-cleavage of the intein tag and release of
the target protein was induced by quickly flushing the column with 2 column volumes of 75
mM DTT (Dithiothreitol, Sigma) in buffer C followed by incubation at room temperature for
ca. 20 h. PCBP2 co-eluted with a small protein (~1.6 kDa); the small protein dialyzed out
and PCBP2 protein concentrated by centrifuging using a 10 kDa cutoff centrifugal filter
(Milipore). Final protein concentration was measured using Advanced assay (Biorad) and
simultaneously by absorbance at UV280.
2.3.2 Mass Spectrometry
The molecular size of PCBP1 and PCBP2 protein monomers were verified using
Matrix-Assisted Laser Desorption Ionization (MALDI-TOF), an instrument available at the
Proteomics Core Facility at Wayne State University. Sample preparation consisted of
desalting protein samples using Zeba spin columns (Pierce) with a 7,000 Da cutoff. Then 1
µL of protein was spotted on a MALDI plate along with 1 µL of sinapinic acid matrix. Protein
mass was determined using an external calibration with a two-point calibration based on
16952.56 Da (apomyoglobin singly charged) and 33904 Da (dimer of apomyoglobin).
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2.3.3 Size Exclusion Chromatography
Size exclusion chromatography was used to measure equilibrium states of PCBP
oligomers. A 120 ml bed volume S-200 gel filtration column, equilibrated with buffer D
(50mM Tris [pH 7.6], 150mM Nacl) was used as the column running buffer. The proteins
were concentrated down to 1ml to reach a concentration of 700µM and then run on the
column at a slow flow rate of 0.5 ml/min. Proteins standards (Bio-Rad) of vitamin B12 (1.3
kDa), myoglobin (17 kDa), ovalbumin (44 kDa), γ-globulin (158 kDa) and thyroglobulin (670
kDa) resuspended in buffer D, were used for comparison of molecular size.
2.3.4 Circular Dichroism
Protein secondary structure was determined using Circular Dichroism spectrsoscopy.
Spectra were collected on an Applied Photophysics π*-180 CD spectrometer using 0.02 cm
quartz CD cell (Hellma Cells Inc., USA). Multiple independent PCBP1 and PCBP2 samples
were prepared at a concentration of ~5 µM in 1 mM NaPO4 buffer at pH 7.6. Three
independent spectra were collected over a wavelength range of 190-260 nm under a 10 nm
resolution. All CD spectra were collected at 23 ºC. Baseline correction was accomplished by
subtracting a buffer spectrum from the 3 averaged spectra, and a mathematical smoothing
option was used to generate the protein’s CD spectrum. Spectral simulations were utilized
to determine the extent of individual secondary structural elements for each protein;
simulations were performed using the CDNN software package provided by Applied
Photophysics.
2.3.5 Isothermal Titration Calorimetry
ITC was used to obtain the thermodynamic parameters related to PCBP1 and PCBP2
iron binding. Sample preparation methods and data collection procedures for PCBP1 have
previously been described and mimicked for PCBP2 with only minor adjustments as
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outlined below. PCBP2 was dialyzed into buffer D using a 10 kDa cutoff centrifugal filter,
concentrated down to 16 µM and degassed on the ThermoVac (accessory provided with the
ITC instrument) to remove all air bubbles prior to loading into the ITC cell. An anaerobic
solution of Ferrous Ammonium Sulfate (Fe(NH4)2(SO4)2•6H2O, Fisher Scientific Co.)
prepared on a Schlenk Line in the matched buffer to that used from the protein during
dialysis was loaded into the ITC syringe. Titrations of Fe(II) aq into PCBP2 were conducted
using a 2 µl

initial controlled aliquot (point removed from fitting analysis) followed by

consecutive 10 µl injections. Independent reproducible experiments were conducted at 25
°C with a stirring speed of 351 rpm. Settling times between 900 – 3800 s between injections
were used to establish equilibrium before the next injection. Data fitting analysis was done
using the Origin 7.0 Scientific Graphing and Analysis Software provided by Micro Cal.
2.3.6 X-ray Absorption Spectroscopy
X-ray Absorption Spectroscopy gives detailed information about the coordination
geometry, oxidation state and structural properties of the bound metal. This method was
exploited to obtain the electronic properties of the metal bound to PCBP1 and PCBP2.
Protein samples were exchanged into degassed buffer D and concentrated using a 10 kDa
cutoff centrifugal filter (Millipore). A ferrous ammonium sulfate solution was prepared under
strict anaerobic conditions as for protein loading. The iron solution was added to the protein
according to a stoichiometric ratio of 1:3, a value corresponding to results obtained by ITC,
and samples were diluted anaerobically with 30% glycerol. Holo-PCBP1 and PCBP2
samples were prepared in an argon filled glove box. Samples were incubated for ca. 30 min
to ensure complete iron binding, loaded into Lucite cells wrapped in Kapton tape and flash
frozen in liquid nitrogen. Samples were removed from the glove box in liquid nitrogen and
directly transferred to our liquid nitrogen filled shipping dewar.
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XAS data were collected at the Stanford Synchrotron Radiation Laboratory (SSRL),
using beamline 7-3, and at the National Synchrotron Radiation Laboratory, using beamline
X3b. Both beamlines are equipped with a 30 element germanium solid-state array detector.
While 7-3 utilized a Si[220] double-crystal monochromator with harmonic rejection mirror,
X3b utilized a Si[111] single crystal monochromator with focusing mirror. At beamline 7-3,
an Oxford Instruments continuous flow liquid helium cryostat was used to maintain samples
at 10K, while a He Displex cryostat was utilized at beamline X3b and samples were run at
25 °C. Protein fluorescence excitation spectra were recorded using 5 eV steps in the preedge region (6900-7094 eV), 0.25 eV steps in the edge region (7095-7135 eV), and 0.05 Å-1
increments in the extended X-ray absorption fine structure (EXAFS) region (to k =13.0 Å-1),
integrating from 1 to 20 s in a k3-weighted manner for a total scan length of approximately
40 min. An iron foil absorption spectrum was simultaneously collected with the protein
sample for calibrating the X-ray energies. The first inflection point for the Fe-foil edge was
assigned at 7111.3 eV. Prior to averaging the scans, each fluorescence channel of every
scan was screened for spectral anomalies. PCBP1 data represents the average of 5 scans
while that of PCBP2 are an average of 12 scans.
XAS data were processed using the Macintosh OS X version of the EXAFSPAK
program suite integrated with the Feff version 7.2 software for theoretical model generation
(11, 12). Analysis of the XANES 1s→3d transitions was performed using the EDG_FIT
subroutine within EXAFSPAK (12). Processing of pre-edge transitions were performed
according to previously established protocols (13). XAS data reduction utilized a second
order polynomial fit in the pre-edge region and a three-region cubic spline in the EXAFS
region. EXAFS data were converted to k space using an E0 value of 7130 eV. EXAFS fitting
analysis were performed according to our previously published protocol (13). During fitting
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analysis, metal-ligand coordination numbers and E0 were fixed, while only the absorberscatterer bond length (R) and Debye-Waller factor (s2) were allowed to freely vary.
2.3.7 Mössbauer Spectroscopy
Mössbauer spectroscopy was used to characterize Fe speciation and metal electronic
characteristics of iron bound to PCBP1 and PCBP2. Protein loaded with Fe57 at 2.1 mM
concentration for PCBP1 and 600µM for PCBP2, were prepared anaerobically in buffer D
by first dissolving metal in a 1:1 mixture of HCl and HNO3, diluting the metal with water to a
final iron concentration of 80 mM ([HCl] – 120 mM, [HNO3] - 150 mM). An aliquot of the 80
mM Fe stock solution was removed and reacted with a 1:1 molar ratio of sodium dithionite
and added to the protein sample for the final iron concentration as mentioned above. The
holo-PCBP samples were then incubated anaerobically for 30 min and frozen in Mössbauer
sample cups cooled using an aluminium block pre-cooled with liquid nitrogen. All samples
were stored under liquid nitrogen until the spectra were collected. Mössbauer spectra were
collected using a MS4 WRC model spectrometer (SEE Co., Edina, MN) equipped with a
CCR4K closed cycle helium compressor (Sumitomo Cryogenetics), at 6 K and 0.05 T, with
the applied field oriented parallel to the gamma rays. Spectra were analyzed using the
WMOSS software package (SEE Co., Edina, MN). All values for the isomer shift and
quadropole splitting are reported relative to the alpha Fe foil at a temperature of 298 K.
2.4 Results
2.4.1 Isolation and purification of PCBP1 and PCBP2
In order to ensure optimal protein production, we performed an extensive expression
test by varying different temperatures of induction, IPTG concentrations, incubation times
and OD’s of induction for PCBP1 and PCBP2 (Figure S2.1). The optimal condition chosen
for further purification of the tagged proteins included expression under the following
parameters: induction at an OD 1.0600 with 0.4mM IPTG and grown at 16 ºC for 22 h after
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induction. Following our established purification protocol, we were able to obtain >95% pure
protein of PCBP1 and PCBP2. Qualitative certification of the correct molecular size for the
proteins came from gel analysis, where PCBP1 and PCBP2 eluted out at 37.525 kDa and
38.580 kDa respectively when visualized on a SDS-PAGE gel (Figures S2.2A and B).
2.4.2 Molecular Characteristics of PCBP1 and PCBP2
Protein size and oligomeric state were verified by mass spectrometry and size
exclusion chromatography, respectively. Samples sizes of 37.535 kDa ± 10 Da (PCBP1)
and 38.578 kDa ± 10 Da (PCBP2) (Figures S2.3A and B) were obtained by mass
spectrometry on purified protein, and were within error bars of theoretical sizes calculated
from the protein sequences (37.525 kDa and 38.580 kDa, respectively).

The general

oligomeric state of each protein was measured by size exclusion chromatography (Figure
S2.4), with both proteins eluting off of a S-200 column with the major band at ~75 kDa,
consistent with the dimeric form of each protein. A second peak was observed in the void
volume, which was most likely from some of the protein aggregating and/or higher order
impurities. It was possible to separate the fractions corresponding to the two peaks and the
dimeric form of the protein was used for further experimentation.
2.4.3 Secondary Structure Determination
Circular Dichroism spectroscopy was used to confirm the general secondary structure
of each protein. Spectra were collected in the far-UV range (190-260 nm) and simulated to
determine the extent of the major secondary structural components that linearly add to the
overall spectrum. Figure 2.1 suggests both proteins are predominately helical in nature.
Spectral simulations confirm a large extent of the secondary structure of PCBP1 (ca. 84%)
and of PCBP2 (ca. 76%) are helical in nature.

To a minor extent, ca. 2% and 4%
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Figure 2.1: CD spectra of apo-PCBP1 and apo-PCBP2. CD spectrum of apo-PCBP1
(solid) and apo-PCBP2 (dashed) at 23 ºC in 1mM sodium phosphate pH 7.6. Apo-PCBP2
spectrum offset by 1×107 units for clarity. Displayed spectra represent a smoothed
average of 3 scans.

Table 2.1 Summary of CD secondary fold of PCBP1 and PCBP2
Secondary
structure
Characteristic

PCBP1(%)

Standard
Deviation(%)

PCBP2(%)

Standard
Deviation(%)

Alpha helix

83.50

0.66

76.30

2.10

Anti parallel

0.90

0.01

2.00

0.54

Parallel

1.10

0.13

2.20

0.25

Beta turn

12.60

0.22

14.80

0.84

Random coil

1.90

0.29

4.70

0.79
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respectively were determined to be β-strand and ca. 13% and 15% respectively were
measured to be turns as additional structural components of both proteins (Table 2.1).
2.4.4 Binding affinity determination using Isothermal Titration Calorimetry
ITC was used to characterize the energetics and stoichiometry of iron binding to
PCBP1 and PCBP2. Titrations of iron into PCBP1 has been performed earlier and
published, with the following binding affinities and stoichiometries of N1= 0.74±0.1, N2 =
2.12± 0.2, KD1 = 0.88±0.1 µM and KD2 = 5.89±0.3 µM (3). In comparison, titrations of ferrous
iron into PCBP2 yielded the raw isotherm in Figure 2.2A. An integration of the area under
the spikes gave the total heat released per injection of the ligand metal into the protein
(Figure 2.2B). The heat release follows a strongly exothermic behavior. Heat release
saturates towards the end indicating that the binding interaction between Fe(II) and PCBP2
is complete, resulting in smaller spikes, arising from the heat of dilution of ferrous iron
alone. The data best fit with a model of two sets of binding sites. The results of the curve
fitting analysis are summarized in Table 2.2. Dissociation constants for iron binding to
PCBP1 and PCBP2 are both in the micromolar range. In the case of PCBP1, there are 3
iron atoms per protein molecule binding at independent sites and with PCBP2, the
stoichiometry of Fe(II) binding to the protein is higher. The difference in the stoichiometry of
Fe(II) binding to PCBP1 and PCBP2 suggest possible non-redundant roles in their function
as iron chaperones.
2.4.5 Electronic environment of bound metal
XAS was utilized to characterize the electronic and structural characteristics of iron
bound to PCBP1 and PCBP2. X ray Absorption Near Edge Spectroscopy (XANES) was
used to characterize the oxidation and spin states of iron bound to PCBP1 and PCBP2.
Extended X ray Absorption Fine Structure (EXAFS) spectroscopy was used to: determine
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Figure 2.2: ITC of Fe(II) into PCBP2. (A) Raw isotherm of heat released per injection of
ligand into protein. (B) Simulated fit of the raw data. Data were collected anaerobically at
25 °C in buffer containing 50 mM Tris [pH 7.6],150 mM NaCl.
Table 2.2: ITC fitting summary of PCBP1 and PCBP2
Sample

N1

KD1 (µM)

N2

KD2 (µM)

PCBP1 + Fe(II)

0.74 ± 0.1

0.88 ± 0.1

2.12 ± 0.2

5.89 ± 0.3

PCBP2 + Fe(II)

3.80 ± 0.1

0.19 ± 0.04

5.01 ± 0.1

8.85 ± 0.96
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nearest neighbor ligands that directly coordinate the metal, the metal-ligand bond distance,
the coordination geometry and ligand symmetry of the bound metal (14). Comparison of the
analysis of the iron XAS from both indicate the proteins have similar metal binging sites.
Analysis of the XANES region of the spectra revealed that majority of the iron bound to
the proteins is in the ferrous form. Figure 2.3 shows a comparison of the XANES plots of
holo-PCBP1 and holo-PCBP2. The first inflection edge energy for an Fe(II) control (FeSO4)
occurs at 7123.6 eV and that for an Fe(III) control (Fe2(SO4)3) occurs at 7127.2 eV.
Comparison of the edge inflection energies for PCBP1 and PCBP2, which occur at 7123.5
and 7123.3 eV respectively, reveals iron bound to both proteins is stable in the ferrous form.
The pre-edge region of the XANES spectra, centered at 7112 eV, was analyzed separately
and areas under the normalized pre-edge peaks calculated, to give values of 12.67 × 10-2
and 10.14 × 10-2 eV for PCBP1 and PCBP2, respectively (Inset of figure 2.3). Pre-edge area
values suggest protein bound metal is in a partially distorted 5-coordinate to 6-coordinate
metal-ligand environment for PCBP1 and PCBP2 (15-17). The area under the pre-edge was
measured from three individual transitions at 7111.31, 7112.92 and 7114.48 eVs for PCBP1
and 7111.42, 7113.01 and 7114.10 eVs for PCBP2. A comparison of these transition
energies with those from iron models (15), indicates iron bound to PCBPs 1 and 2 is
consistent with high spin Fe(II) compounds.
Analysis of the EXAFS indicates Fe(II) bound to PCBPs has an O/N based ligand
environment. Raw EXAFS data with Fourier transformed magnitude for samples with 3
Fe(II) bound to PCBP1 and PCBP2 are shown in Figure 2.4. Spectral simulations of the
EXAFS confirm the best fit simulation arises from two independent environments of nearest
neighbor ligands, all oxygen/ nitrogen based, at resolvable bond-lengths of 1.94-1.97 Å and
2.12-2.13 Å (Table 2.3). Long-range carbon scattering is observed in both PCBP1 and
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Figure 2.3: XANES comparison of holo-PCBP1 and holo-PCBP2. Full XANES spectra of
PCBP1 with 3 iron (solid) and PCBP2 with 3 iron (dashed). PCBP2 spectrum offset by 0.6
units for clarity. Inset: Expansion of the background subtracted 1s→3d region of the XANES
spectra. PCBP2 pre-edge spectrum offset by 0.025 units for clarity.
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PCBP2. The bond-lengths and the coordination numbers are consistent with a partially
symmetric six (or five)-coordinate Fe(II)- O/N ligand environment (18). The presence of
O/Ns at two different bond lengths indicates a partial bond asymmetry in the Fe nearest
neighbor ligands (Table 2.3).
2.4.6 Iron speciation by Mössbauer Spectroscopy
Mössbauer spectroscopy was used to investigate the metal-protein speciation and
metal electronic characteristics of holo-PCBP1 and holo-PCBP2. The Mössbauer spectra of
3Fe(II) bound PCBP1 and PCBP2 are shown in Figure 2.5. The raw data is represented as
bold solid black lines while simulations are shown in thin solid black. The spectrum of
aqueous High-Spin (S = 2) Fe(II) ions in 100 mM Tris buffer [pH 8.5], used in incubating
with apo-proteins, represents a low-field 6 K Mössbauer signal (Figure 2.5, A). The
equivalent spectrum of PCBP1 and 2 after addition of 3 molar equivalents of the Fe stock
are given in Figure 2.5 B and C,respectively. The results of the simulation for the three
spectra are summarized in Table 2.4. For PCBP1, the simulation was carried out assuming
two quadrupole doublets of equal intensity. It was possible to obtain an equivalent
simulation using two doublets with slightly different values as summarized in Table 2.4.
PCBP2 simulation was done with a single set of values.
Mössbauer spectroscopy indicates Fe bound to PCBP1 and 2 is high-spin Fe(II). There
is a shift in parameters for Fe bound to the proteins as compared to the Fe(II) control
indicating iron bound to the proteins is unique from the aqueous iron control. Protein bound
iron is dominated by ligands provided by a protein and PCBP1 and PCBP2 therefore
directly coordinate metal. The shift in parameters would be consistent with the increased
presence of N-donor ligands. The increase in linewidth reflects more than one unique metal
binding site.
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Figure 2.4: EXAFS and Fourier transforms of holo-PCBP1 and holo-PCBP2. Exafs
spectra in solid black for 3Fe bound PCBP1 (A) and 3Fe bound PCBP2 (C), along with the
corresponding Fourier transforms (B and D, respectively). Simulations for EXAFS and FT
data are shown in dashed lines.
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Table 2.3: Summary of EXAFS Simulation Analysis for Fe(II)-Loaded PCBP1 and
PCBP2a

Fenearest neighbor ligandsb

Felongrange ligandsb

sample

atomc

R (Å)d

CNe

σ 2f

atomc

R (Å)d

CNe

σ 2f

F′ g

PCBP1

O/N

1.97

1.5

5.03

C

2.98

1

3.46

0.18

O/N

2.12

3.5

4.20

C

3.11

2

3.22

C

3.50

1

3.50

C

4.17

1

1.57

PCBP2

aValues

O/N

1.94

1.5

2.19

C

3.03

2

2.60

O/N

2.13

4.5

2.57

C

3.23

1.5

2.69

C

3.53

0.5

4.70

C

4.15

2.5

1.79

0.19

given in table represent the best‐fit simulation parameters for k=1 to 13. bIndependent metal‐ligand

scattering environment. cScattering atoms: O(oxygen), N(nitrogen) and C(carbon). dMetal‐ligand bond length
(all standard deviations < 0.03 Å). eMetal‐ligand coordination number (all standard deviations < 1.0). fDebye‐
Waller factor given in Å2 × 103 (all standard deviations < 0.9 Å). gNumber of degrees of freedom weighted
mean square deviation between empirical and theoretical data.
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C

Figure 2.5: Mossbauer spectra of holo-PCBP1 and holo-PCBP2 with Fe(II) model.
Low-field 6 K Mossbauer spectrum in bold, solid black of (A) Aqueous High-Spin (S = 2)
Fe(II) ions in 100 mM Tris buffer [pH 8.5] used in incubating with apo-proteins (B) 3Fe
bound PCBP1 and (C) 3Fe bound PCBP2. The solid black line is a simulation of the raw
data.
Table 2.4 Summary of Mossbauer Simulation Analysis for Fe(II) bound PCBP1 and
PCBP2a

Parameters

Fe(II) control

(mm/s)
δ

b

ΔEQ
Γ
a

c

d

PCBP1

PCBP2

Simulation 1

Simulation 2

1.36

1.25

1.25

1.39

1.15

1.19

3.26

3.18

2.54

2.29

2.92

3.13

0.36

0.43

0.50

0.47

0.47

0.48

b

c

Values given in table represent the best-fit simulation parameters. Isomer shift. Electric Quadrupole
d

Splitting. Linewidth
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2.5 Discussion
The initial report indicating PCBP1 as an Fe chaperone in the delivery of metal to
ferritin showed PCBP1 interacts with ferritin only in the presence of iron(3). Following this,
we also reported that the PCBPs physically interact with prolyl-hydroxylase-2 (PHD2) and
deliver iron to this enzyme(10). The same studies suggested the PCBPs are directly
involved in the activation of the asparaginyl hydroxylase FIH1 following metal delivery. The
protein-protein interactions do not take place without metal. Iron binding to the PCBPs
would therefore be the first step for metal delivery. We establish in this report that in vitro,
PCBP1 and PCBP2 physically interact with and bind iron. Our biophysical characterization
of these iron binding events lead to a better understanding of key in vivo events related to
iron homeostasis.
The binding affinities for PCBP1 and PCBP2 with ferrous iron are both in the
micromolar range. These affinities are typical of other proposed iron chaperones (19) (20).
Weak binding affinities in this range are consistent with the high iron concentrations in cells
and are functionally consistent with the idea that proteins must be able to bind metal tight
enough to hold it but also loose enough to be able to deliver it. Frataxin, a putative
mitochondrial iron chaperone that delivers iron for the formation of Fe-S clusters has Kd's of
3.8, 3.2, 6.0 and 55 µM repectively for its bacterial, yeast, fly and human orthologs (13, 2123)
The dissociation constants measured for iron binding to PCBP1 (KD1 = 0.88 and KD2 =
5.80µM) and PCBP2 (KD1 = 0.19 and KD2 = 8.85µM) fall within the range as measured for
these other putative Fe chaperone proteins. This suggests a common theme in how cells
may be utilizing metalloproteins to deliver iron to target proteins both in the mitochondria
and the cytosol. Both PCBP1 and PCBP2 exhibit tighter binding in the first binding site and
a weaker binding affinity in the second site. The weaker binding site may be the initial
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delivery site or it may arise from a buffer effect of metal binding to the tris buffer. Published
ITC experiments for Fe2+ titrated into recombinant human H-chain apoferritin (HuHF) show
dissociation constants also in the micromolar range (24). Since the metal binding affinities
of the delivery protein and the target protein are similar, it is reasonable to believe that the
PCBPs can serve as iron chaperones to ferritin. The high sequence similarity between
PCBP1 and PCBP2 (81%) might suggest their functions may be similar or even identical,
however ITC results suggest otherwise. PCBP1 binds three iron atoms while PCBP2 binds
nine. This difference in their binding ability suggests a non-redundant role in their function.
Our recent unpublished work in mammalian cells demonstrates that depletion of either
protein leads to defects in ferritin iron loading. If PCBP1 and PCBP2 were functionally
redundant, cells would have to be depleted of both proteins in order to demonstrate defects
in iron delivery, but that is not the case in mammalian cells. The two proteins perhaps bind
different number of iron atoms in order to be able to perform their unique roles as iron
chaperones. What the exact differences in their functions are and whether these differences
enable them to carry out independent functions more efficiency are questions that can only
be answered with further experiments. Nevertheless, given that the binding affinities for
both PCBP1 and PCBP2 are typical of other metal chaperones, it is plausible to suggest
both proteins are iron chaperones.
XANES spectra provide insight regarding metal oxidation state, metal-ligand
coordination geometry/symmetry and the spin state of iron (14). The FeSO4 model has an
inflection energy of 7123.6 eV and the corresponding ferric model Fe2(SO4)3, has a
distinguishable energy value of 7127.2 eV.

The first inflection edge energies for holo-

PCBP1 and holo-PCBP2 (Figure 2.3) are very similar to each other and have a value of ca
7123.4 eV, consistent with the ferrous control. Ferritin and prolyl-hydroxylase-2 (PHD2)
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require ferrous metal at the initial stages of activity, so metal chaperones that retail Fe(II)
are consistent with delivery to these protein partners
EXAFS spectra provide structural and electronic details about the bound metal (14).
The five to six nearest neighbor ligands for the PCBPs occur at bond distances of 1.96 Å
and 2.12 Å, consistent with Fe(II)-O/N six coordinate model compounds. The shorter bond
length at 1.96 Å is consistent with iron bound to bi-dentate ligands from carboxylate
residues (25). Fe-N bond lengths are on average longer than Fe-O distances (26),
suggesting the 2.12 Å interaction could arise from nitrogens bound to imidazoles. However,
these bond lengths are also observed in six coordinate Fe(II)–O6 compounds when oxygen
is coordinated to a carboxylate or H2O (13). Therefore, a bond length at 2.12 Å suggest
Fe(II) is bound by histidines, acidic residues, H2O or most likely by some combination of all
three.
The reduced coordination number observed for PCBP1 (CN=5) could indicate a lower
coordination number for the metal.

However, given the similarity in bond lengths with

authentic 6 coordinate Fe-O/N system, this value most likely suggests a decrease in
coordination geometry symmetry for iron coordinated to PCBP1. The high Debye-Waller
factors of 5.03 × 10-3 Å2 and 4.20 × 10-3 Å2 respectively for O and N coordinated to Fe in the
protein, are consistent with this hypothesis. The area under the pre-edge peak, which is an
excellent indication of coordination geometry and symmetry (16), has a slightly higher value
of 12.67 × 10-2 eV for PCBP1 as compared to the value of 10.14 × 10-2 eV for PCBP2,
however both are consistent with 6 coordinate Fe(II) model compounds. This higher value
for PCBP1 suggests a more distorted metal-ligand symmetry.
PCBP1 and PCBP2, show long range carbon scattering that typically arises from
carbons atoms in an imidazole ring. The long –range carbon scattering at c.a 3.0 Å is also
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typical of scattering interactions at a distance observed for Fe(II)-C from carbons in a
carboxylate ligand. No Fe-S ligation was detectable, indicating these proteins do not employ
cysteines to bind metal. From EXAFS data, it is therefore possible to conclude that the
protein most likely binds metal using acidic residues and/or histidines.
Mössbauer spectroscopy is a powerful tool for understanding metal speciation and
metal oxidation state for iron bound to proteins (27). Mossbauer also indicates that the
metal bound to the protein is mostly reduced, a result supported by the edge analysis of
XAS. Both PCBPs show a doublet in their low temp Mossbauer spectra caused by
quadrupole splitting. The broadening in spectral linewidth for both indicates the presence of
more than one metal binding site; from spectral simulations there could be up to three
unique states. Considering both proteins bind multiple iron atoms, it is reasonable to expect
there should be more than one metal binding. Since the two proteins have three KH
domains, the mechanism of metal binding may be similar to those of well studied
metalloproteins, such as some Zn finger proteins, which open and fold its fingers to bind
and hold metal (28). Structural characterization of both apo and holo proteins is required to
completely understand the identity of the metal binding sites on the protein and the
mechanism of metal binding.
Considering the similarity in bound iron electronic environments and binding affinities
of the PCBPs, it seems likely the two proteins employ a similar mechanism to bind and hold
metal. Why would the cell employ two proteins for the same purpose of iron delivery?
Clearly, their function is non-redundant, since PCBP2 cannot replace activity in PCBP1
knockdown-mice (10). One possible explanation is the diversity of iron stores in different
tissues and the related need for the chaperone to be able to deliver tissue specific amounts.
Depending on the specific function that a tissue or cell type needs to carry out, it has its own
defined iron levels (29). Animal red blood cells, for example, maintain high iron levels
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required for their function of haemoglobin synthesis. The leaves of plants synthesize
ferredoxins and they have a relatively higher iron content. Hence it makes sense that there
should be different iron chaperones to deliver and load tissue specific iron quantities into
ferritin. While the number of iron chaperones is unknown, we have provided details of at
least two of them, PCBP1 and PCBP2, by showing they both bind iron and can selectively
load iron into ferritin. Consistent with this explanation is our observation from ITC that the
two proteins bind different amounts of iron. It could be that the two proteins may be
functioning in cooperation with each other or their primary target enzymes may be different.
Also, they do not load ferritin equally in vitro as demonstrated by ITC in chapter 4.
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2.7 Supplementary Figures

Figure S2.1: Flow chart of expression test to determine the best expression
condition for PCBP1 and PCBP2. Different temperatures, OD’s of induction, IPTG
concentrations and incubation times were tested.
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Figure S2.2 SDS-PAGE gels showing pure (A) PCBP1 at 37.525 kDa and (B) PCBP2 at
38.58 kDa

Figure S2.3: Molecular weight determination using MALDI mass spectrometry
(A) PCBP1 (B) PCBP2
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Figure S2.4: Size exclusion chromatograms of apo PCBP1 (dashed), apo PCBP2
(dashed and dotted) in comparison with protein standards (solid). Samples were run
on a S-200 Sephacryl size exclusion column.
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CHAPTER 3
BIOPHYSICAL CHARACTERIZATION OF THE FERRITIN IRON CHAPERONE, PCBP3
3.0 Prelude
Mammalian genomes contain four PCBP paralogs (1). Two of the family members,
PCBP1 and PCBP2 were recently discovered to be iron chaperones to ferritin (2).
Experiments aimed at characterizing their iron binding and delivery properties have been
performed and described in Chapter 2. A major question that emerged from the initial
studies of PCBP1 and 2 was whether the other family members were involved in metal
delivery events as well. Initial in vivo experiments showed expression of PCBP3 in yeast
activated the iron deficiency response, exhibited strong interactions with ferritin and strongly
increased iron loading into ferritin. This led us to the logical next question – Is it possible to
verify in vitro a direct binding interaction between PCBP3 and iron? To answer this question
and to better understand the role of PCBP3 in ferritin iron loading, we performed a
comprehensive characterization of the metal binding properties of PCBP3, which are
reported here in Chapter 3. The protocols for the experiments performed are very similar to
those reported in Chapter 2 (with slight modifications) and these are outlined below. To our
knowledge, this is the first time a study directed at understanding the role of PCBP3 as a
metal chaperone has been performed and is published here. A summer internship in Dr.
Caroline Philpott’s lab at NIH provided the perfect opportunity to initiate this project, which
was then continued in the P.I. Dr. Stemmler’s lab. This chapter is a summary of the results
but is not yet being prepared for publication as this project is still in its early stages.
3.1 Introduction
PCBP3 is the third member in the PCBP family of proteins that share a common triple
KH domain. This chapter discusses experiments that were performed specifically to provide
a basic characterization of the biophysical properties of PCBP3 before metal loading, and to
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characterize the binding, structure and electronic properties of iron bound to the protein.
Basic characterizational experiments included using mass spectrometry to confirm the
molecular weight of the protein, size exclusion chromatography to obtain the protein
oligomeric state and circular dichroism to determine the secondary structure of the protein.
Metal binding characteristics were investigated using isothermal titration calorimetry (ITC)
and Mossbauer spectroscopy techniques. Combined, these studies help clarify the
molecular picture of how the PCBP3 participates in metal transfer to ferritin.
3.2 Experimental Methods
3.2.1 Protein expression and Purification
Human PCBP3 was cloned into a pESUMO vector (Life Sensors) and transformed into
BL21∗ Escherichia coli competent cells containing Ampicillin resistance. Cells were grown in
1L TB media at 37°C to an OD600 of 2.0, induced with a IPTG concentration of 0.1 mM and
then grown for 22 h at 15°C. Cells were collected and resuspended in 50 ml of buffer A
(20 mM Tris [pH 7.9], 250 mM NaCl, 30 mM imidazole, 20% glycerol, and 2.5 mM TCEP)
with an EDTA-free protease inhibitor cocktail tablet (Roche) /50 ml, 30 mgs of lysozyme and
20 µg/mL of DNAse. Samples were sonicated and then homogenized by two passes in an
emulsiflex. The extract was spun at 22,000 rpm for 1 h and loaded on a nickel column.
Separation was carried out using a gradient between buffer A and buffer B (20mM Tris [pH
7.9], 250 mM NaCl, 500 mM imidazole, 20% glycerol, 2.5 mM TCEP). The SUMO tag was
cleaved by adding 1/1000 concentration SUMO protease and incubating overnight at 4°C.
Protein was buffer exchanged with buffer A before passing on the nickel column again to
separate the tag from untagged protein. The protein was run on a S-200 gel filtration
column (GE Healthcare) and it eluted out at a molecular weight of ~83 kDa, consistent with
the dimeric form of the protein. All buffers were purged with argon for one hour before use
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on the column. Protein was concentrated by centrifuging using a 10 kDa cutoff centrifugal
filter (Milipore) and final protein concentration was measured using a BCA assay (Thermo
Scientific) and simultaneously by absorbance at UV280.
3.2.2 Mass spectrometry and size exclusion chromatography
The molecular size of PCBP3 was verified using the Q Exactive mass spectrometer
with EASY nLC ultra-high pressure liquid chromatrography system (Thermo
Scientific), an instrument available at the Proteomics Core Facility at Wayne State
University. Sample buffer was adjusted to 5% acetonitrile, 0.1% formic acid, and 0.005%
trifluoroacetic acid. Proteins were desalted on-line and separated by reverse phase
chromatography before introduction into a Q Exactive mass spectrometer (Thermo
Scientific). MS settings included 70,000 resolution, AGC target = 1 x 106, 1 microscan,
positive mode, in-source CID = 20.0 eV, maximum ionization time = 100 ms and a 600-2500
m/z scan range. Average molecular mass estimations were determined using MagTran
software (ver 1.03b2).
Size exclusion chromatography was used to measure equilibrium states of apoPCBP3. A 120 ml bed volume S-200 gel filtration column, equilibrated with buffer D (50 mM
Tris [pH 7.6], 150 mM Nacl) was used as the column running buffer. The protein was
concentrated down to 1 ml to reach a concentration of ~700 µM and then run on the column
at a slow flow rate of 0.5 ml/min. A sample of PCBP3 incubated with excess ferrous iron
was independently run on the column and the chromatogram obtained. Proteins standards
(Bio-Rad) of vitamin B12 (1.3 kDa), myoglobin (17 kDa), ovalbumin (44 kDa), γ-globulin
(158 kDa) and thyroglobulin (670 kDa) resuspended in buffer D, were used for comparison
of molecular size.
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3.2.3 Circular Dichroism
Protein secondary structure was determined using Circular Dichroism spectrsoscopy
(3). Spectra were collected on an Applied Photophysics π*-180 CD spectrometer using
0.02 cm quartz CD cell (Hellma Cells Inc., USA). Multiple independent PCBP3 samples
were prepared at a concentration of ~9 µM in 1 mM NaPO4 buffer at pH 7.6. Nine
independent spectra were collected over a wavelength range of 190-260 nm under a 10 nm
resolution. All CD spectra were collected at 23 ºC. Baseline correction was accomplished by
subtracting a buffer spectrum from the 9 averaged spectra, and a mathematical smoothing
option was used to generate the protein’s CD spectrum. Spectral simulations were utilized
to determine the extent of individual secondary structural elements for each protein.
Simulations were performed using the CDNN software package provided by Applied
Photophysics.
3.2.4 Isothermal Titration Calorimetry
ITC was used to obtain the thermodynamic parameters related to PCBP3 iron binding
(4). Sample preparation methods and data collection procedures for PCBP1 have
previously been described (2) and mimicked for PCBP3 with only minor adjustments as
outlined below. PCBP3 was dialyzed into buffer D using a 10 kDa cutoff centrifugal filter,
concentrated down to 10 µM and degassed on the ThermoVac (accessory provided with the
ITC instrument) to remove all air bubbles prior to loading into the ITC cell. An anaerobic
solution of Ferrous Ammonium Sulfate (Fe(NH4)2(SO4)2•6H2O, Fisher Scientific Co.) at a
concentration of 2 mM, prepared on a Schlenk Line in the matched buffer to that used for
the protein during dialysis was loaded into the ITC syringe. Titrations of Fe(II) aq into
PCBP3 were conducted using a 2 µl initial controlled aliquot (point removed from fitting
analysis) followed by consecutive 10 µl injections. Independent reproducible experiments
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were conducted at 25 °C with a stirring speed of 351 rpm. Settling times between 600 –
2100 s between injections were used to establish equilibrium before the next injection. Data
fitting analysis was done using the Origin 7.0 Scientific Graphing and Analysis Software
provided by Micro Cal.
3.2.5 Mössbauer Spectroscopy
Mössbauer spectroscopy was used to characterize Fe speciation and metal electronic
characteristics of iron bound to PCBP3 (5). A sample of PCBP3 was loaded with Fe57 at a
ratio of 1:1 and prepared anaerobically in buffer D by first dissolving metal in a 1:1 mixture
of HCl and HNO3 and diluting the metal with water to a final iron concentration of 80 mM
([HCl] – 120 mM, [HNO3] - 150 mM). An aliquot of the 80 mM Fe stock solution was
removed and reacted with a 1:1 molar ratio of sodium dithionite and added to the 500 µM
protein sample for the final iron concentration. The holo-PCBP3 samples were then
incubated anaerobically for 30 min and frozen in Mössbauer sample cups cooled using an
aluminium block pre-cooled with liquid nitrogen. All samples were stored under liquid
nitrogen until the spectra were collected. Mössbauer spectra were collected using a MS4
WRC model spectrometer (SEE Co., Edina, MN) equipped with a CCR4K closed cycle
helium compressor (Sumitomo Cryogenetics), at 6 K and 0.05 T, with the applied field
oriented parallel to the gamma rays. Spectra were analyzed using the WMOSS software
package (SEE Co., Edina, MN). All values for the isomer shift and quadropole splitting are
reported relative to the alpha Fe foil at a temperature of 298 K.
3.3 Results
3.3.1 Purification of PCBP3
Purification procedures were carried out as outlined in the experimental section to
obtain >95% pure protein. PCBP3 eluted out at ca. 39465 Da as visualized on a SDS-
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PAGE gel (Figure 3.1). Western blot was carried out to verify that the protein being purified
was in fact PCBP3. Since PCBP3 antibody was not available, PCBP2 antibody that crossreacted with PCBP3 was used advantageously to detect PCBP3 protein. The protein was
clearly detected by western blot as seen in Figure 3.2.
3.3.2 Molecular Characteristics of PCBP3
Protein size and oligomeric state were verified by mass spectrometry and size
exclusion chromatography. Sample size of 39460 ± 7 Da (Figure 3.3), obtained by mass
spectrometry on purified protein, w within error bars of theoretical size obtained from the
protein sequence (39465.2 Da). The general oligomeric state of the protein was measured
by size exclusion chromatography (Figure 3.4), with the protein eluting from a S-200 column
with the major band at ~83 kDa, consistent with the dimeric form of the protein. A second
peak was observed in the void volume, which was most likely from some of the protein
aggregating and/or higher order impurities. It was possible to separate the fractions
corresponding to the two peaks and the dimeric form of the protein was used for further
experimentation.
3.3.3 Secondary structure determination
Circular Dichroism spectroscopy was used to confirm the general secondary structure
of PCBP3. Spectra were collected in the far-UV range (190-260 nm) and simulated to
determine the extent of the major secondary structural components that linearly add to the
overall spectrum.

Figure 3.5 suggests the protein is predominately helical in nature.

Spectral simulations confirm a large extent of the secondary structure of PCBP3 (ca. 50%)
is helical in nature. To a smaller extent, ca. 12% was determined to be β-strand, 18% to be
turns and 21% was measured to be random coil as additional structural components of the
protein (Table 3.1).
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Figure 3.1 SDS-PAGE gel showing pure PCBP3 at ~40kDa

Figure 3.2 Western blot detecting PCBP3 in the purified fractions from
pESUMO-PCBP3
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Figure 3.3: Mass spectrometry verifies the molecular weight of PCBP3 as 39460 Da.
The theoretically calculated mass from the sequence is 39465.2 Da. The measured value
is within the error limits of the instrument.

Figure 3.4 PCBP3 elutes out as a dimer at ~83 kDa on a S-200 gel filtration column.
Top panel: Chromatogram of molecular weight standards from Biorad run on the column.
Bottom panel: PCBP3 run on the S-200 column.
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Figure 3.5 CD spectrum of apo-PCBP3. CD spectrum of apo-PCBP3 in 1mM sodium
phosphate pH 7.6 at 23 ºC. Displayed spectrum represents a smoothed average of 9
scans.
Table 3.1: CD secondary structure characteristics of PCBP3
Secondary structure characteristic PCBP3(%)

Standard
Deviation(%)

Alpha helix

49.56

1.16

Anti parallel

5.53

0.53

Parallel

6.19

0.18

Beta turn

17.59

0.22

Random coil

21.13

0.67
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3.3.4 Binding affinity determination using Isothermal Titration Calorimetry
ITC was used to characterize the energetics and stoichiometry of iron binding to
PCBP3. Titrations of ferrous iron into PCBP3 yielded the raw isotherm in Figure 3.6A. An
integration of the area under the spikes gave the total heat released per injection of the
ligand metal into the protein (Figure 3.6B). The heat release follows a strongly exothermic
behavior. Heat release saturates towards the end indicating that the binding interaction
between Fe(II) and PCBP3 is complete, resulting in smaller spikes, arising from the heat of
dilution of ferrous iron alone. The data best fit with a model of two sets of binding sites with
N1 = 7.47 ± 0.69, N2 = 8.85 ± 2.89, KD1 = 1.38 ± 0.27 µM and KD2 = 7.93 ± 1.19µM. The
dissociation constants for iron binding to PCBP3 are in the micromolar range. In the case of
PCBP1, there were 3 iron atoms per protein molecule binding at independent sites and with
PCBP3, the stoichiometry of Fe(II) binding to the protein is higher.
3.3.5 Iron speciation by Mössbauer Spectroscopy
Mössbauer spectroscopy was used as a tool to investigate the metal-protein speciation
and metal electronic characteristics of holo-PCBP3. The Mössbauer spectrum of 1Fe(II)
bound PCBP3 is shown in Figure 3.7. The first spectrum (Figure 3.7A) is a 5K, 500 G
Mossbauer spectrum of PCBP3-1Fe(II) simulated (Red curve) with δ = 1.2 mm/s, ΔEQ =
3.00 mm/s and Γ = 0.55 mm/s. A low-field 6 K Mössbauer spectrum of aqueous high-spin
(S = 2) Fe(II) ions in 100 mM Tris buffer [pH 8.5] was also collected and is shown in red in
Figure 6.7B. In black is an overlay of the PCBP3 + 1eq of Fe(II) spectrum.
Mössbauer spectroscopy indicates that the Fe bound to PCBP3 is high-spin Fe(II).
There is a shift in parameters for Fe bound to proteins as compared to the Fe(II) control,
indicating protein bound iron is in a different environment from the iron in the control and the
iron in the proteins is now dominated by ligands provided by a protein environment. This
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Figure 3.6 ITC of Fe(II) into PCBP3. (A) Raw isotherm of heat released per injection
of ligand into protein. (B) Simulated fit of the raw data. Data were collected
anaerobically at 25oC in buffer containing 50 mM Tris [pH 7.6] 250 mM NaCl.
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Figure 3.7: Mössbauer spectrum of PCBP3-1Fe(II). (A) The 5K, 500 G Mössbauer
spectrum of PCBP3-Fe(II) (black) simulated (Red curve) with δ = 1.2 mm/s, ΔEQ = 3.00
mm/s, Γ = 0.55 mm/s. (B) Overlay of experimental 5K, 500G spectrum of Stock Fe(II)
(Red spectrum) with PCBP3 + 1 eq of Fe(II) (Black Spectrum)

64
strengthens the scope that PCBP3 is directly coordinating metal before trafficking the metal
to target enzymes. Furthermore, the shift in δ and ΔEQ would also be consistent with the
presence of N-donor ligands. Finally, an increase in linewidth reflects more than one unique
metal binding site.
3.4 Discussion
Sequence homology predicts PCBP3 should interact in a manner similar to PCBP1 and
PCBP2. There is a high sequence similarity between PCBP3 and PCBPs 1 and 2 (66%
between PCBP3 and PCBP1 and 68% between PCBP3 and PCBP2). Additionally, all three
proteins share a conserved KH domain morphology. Our in vivo data (unpublished) shows
expression of PCBP3 in yeast activates the iron deficiency response, exhibits strong
interactions with ferritin and strongly increases iron loading in ferritin similar to that observed
for PCBP1 and PCBP2.
Our structural data of apo- and holo- PCBP3 is also similar to that of PCBPs 1 and 2.
Circular Dichroism measurements of apo proteins show that all three proteins are well
folded and have a predominately helical content of 83%, 76 % and 50 % respectively for
PCBPs 1, 2 and 3. In vitro, all three proteins are stable as a dimer. Mossbauer data
suggests a common theme in how these proteins interact with metal. The shift in
parameters for protein bound metal indicates an increase in N-donor ligands. This suggests
that the proteins may be employing a similar mechanism in binding metal by employing
histidine residues. Further, a broadening in linewidth in the Mossbauer spectra observed
with all three holo-proteins suggests more than one unique metal binding site. This is
consistent with the observed Isothermal Titration Calorimetry results. The ITC data for all
three proteins fit best with a two binding site model displaying a tighter binding affinity in the
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first site and a weaker affinity in the second, although the binding affinity is in the micirmolar
range for both the sites in all three proteins.
While there are a number of similarities among the three proteins and in their metal
binding characteristics, there are a few differences that are noteworthy and may elucidate
the key differences in their role as iron chaperones. The number of iron atoms each of these
proteins binds is different as elucidated by ITC. While PCBP1 binds 3 iron atoms, PCBP2
binds 9 and PCBP3 binds 16. The high number of iron atoms they bind makes sense in the
context of their target enzyme ferritin. Ferritin is a dodecamer, with 8 metal entry sites or
pores on its surface (6). This facilitates the delivery of a large number of metal ions to this
protein. Thus, it makes sense that the iron chaperones to the protein also bind a large
number of metal ions; although there are differences in the number of metal ions each of
these chaperones bind. Another important factor to note is that PCBPs 1 and 2 are
ubiquitously expressed, whereas PCBP3 exhibits only limited expression in some tissues.
This is similar to the expression of ferritin, which is high in certain tissues such as the liver
and the brain and limited in others (7). Therefore, we hypothesize that there are tissue
specific PCBPs to deliver tissue specific amounts of iron to ferritin and the function of the
chaperones is non-redundant.
Experiments are underway to test our hypothesis in vivo and to structurally characterize
the metal binding sites on PCBP3. It will be interesting to see if metal site structure of iron
bound to PCBP3 looks similar to that of PCBPs 1 and 2. Other proposed experiments
include testing the binding of Fe(II)+PCBP3 with ferritin using Isothermal Titration
Calorimetry and X-ray Absorption Spectroscopy. Another interesting possibility to be
explored is the binding of PCBP3 with PCBPs 1 and 2 in the presence and absence of iron.
We are only beginning to see the role of PCBP3 as an iron chaperone. Experiments as
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proposed above will help clarify its functional similarities and differences as compared to
PCBPs 1 and 2.
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CHAPTER 4
EACH MEMBER OF THE PCBP FAMILY EXHIBITS IRON CHAPERONE ACTIVITY
TOWARD FERRITIN
4.0 Prelude
The previous two chapters described the iron binding characteristics of three of the
four PCBP family members PCBP1, PCBP2 and PCBP3. The current chapter ties together
these results and extends the study to show that the fourth family member PCBP4 is also
involved in interacting with and binding iron. Furthermore, experiments have been
performed to confirm the direct interaction of metal bound PCBPs with the target enzyme
ferritin. This work has been submitted for publication with the following reference: Leidgens
S., Bullough K. J., Shi H., Shakoury-Elizeh M., Yabe T., Subramanian P., Hsu E., Natarajan
N., Nandal A., Stemmler T.L., and Philpott C. C. “Each member of the PCBP family exhibits
iron chaperone activity toward ferritin.” Journal of Biological Chemistry, 2013 and the work
is reprinted here. The author of this dissertation is a co-author of the paper and her
contribution to this work has been to quantitatively demonstrate (using ITC) that the
interaction between metal bound PCBPs and ferritin is of a high affinity, exhibiting a high
stoichiometry consistent with the multi-subunit character of ferritin, and is entirely dependent
on iron (no interaction is measured in the absence of iron). This is the first, published,
quantitative analysis of the interaction of either PCBP1 or PCBP2 with ferritin.
4.1 Summary
The mechanisms through which iron-dependent enzymes receive their metal cofactors
are largely unknown. Poly r(C) Binding Protein 1 (PCBP1) is an iron chaperone for ferritin;
both PCBP1 and its paralog PCBP2 are required for iron delivery to the prolyl hydroxylase
that regulates HIF1. Here we show that PCBP2 is also an iron chaperone for ferritin. Coexpression of PCBP2 and human ferritins in yeast activated the iron deficiency response
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and increased iron deposition into ferritin. Depletion of PCBP2 in Huh7 cells diminished iron
incorporation into ferritin. Both PCBP1 and PCBP2 were co-immunoprecipitated with ferritin
in HEK293 cells and expression of both PCBPs was required for ferritin complex formation
in cells. PCBP1 and 2 exhibited high-affinity binding of ferritin in vitro. Mammalian genomes
encode 4 PCBPs, including the minimally expressed PCBPs 3 and 4. Expression of PCBP3
and 4 in yeast activated the iron deficiency response, but only PCBP3 exhibited strong
interactions with ferritin. Expression of PCBP1 and ferritin in an iron sensitive, ccc1 yeast
strain intensified the toxic effects of iron, while expression of PCBP4 protected the cells
from iron toxicity. Thus, all PCBP family members may share iron chaperone activity,
although PCBP4 exhibits reduced interaction with ferritin.
4.2 Introduction
Transition metal ions function as essential cofactors for hundreds of cellular proteins
in archaea, bacteria, and eukaryotes. Most metalloproteins contain iron and/or zinc, while a
smaller number contain copper, manganese, cobalt, nickel, and molybdenum [1]. The
simplest model to account for the incorporation of metals into proteins posits a stochastic
process, in which pools of free metal ions interact with nascent polypeptides through
Brownian motion. If the correct metal ion finds its cognate ligand-binding site, the metal
binds and the protein folds into its active form. In this model, the interaction of a metal ion
with a non-cognate binding site is weak and transient.
Several observations make clear, however, that the incorporation of metals onto
proteins is a more complex process that cannot be described using this simplest of models.
First, the protein binding sites that coordinate divalent metal ions can be structurally very
similar and, at least in vitro, accommodate a variety of metal ions with high affinity [1].
Incorporation of the non-native metal ion typically inactivates a metalloprotein. Yet in vivo,
metalloproteins are typically found with only their correct metal ligand. Second, the

69
concentration of “free” metal ions within cells can be extremely low. For example, kinetic
measurements indicate that essentially all cytosolic zinc and copper ions are found tightly
associated with cytosolic binding proteins [2]. Thus, “free” metal ions are not available to
activate enzymes. Third, iron and copper ions are redox active and toxic to cells. These ions
occupy multiple valence states under physiological conditions. Reduced iron and copper
can, in the presence of oxygen, trigger the formation of reactive oxygen species that can
damage many cellular components. Yet cells are capable of maintaining these metal ions in
a usable form that also minimizes their toxicity in an aerobic environment.
Although the mechanisms through which most metalloproteins acquire their cognate
metal ions are unknown, some proteins are activated via metallochaperones: proteins that
bind specific metal ions and deliver them to target proteins via a metal-mediated, proteinprotein interaction [3]. In a genetic screen conducted in budding yeast, human poly (C)binding protein 1 (PCBP1) was identified as an iron chaperone that delivers iron to human
ferritin, a cellular iron storage protein [4]. Mammalian ferritin is a 24-subunit heteropolymer
composed of H- and L-peptides that form a hollow sphere into which iron is deposited [5].
Ferrous iron binds to ferritin via carboxylate side chains that line the pores formed between
adjacent subunits on the three-fold axis of symmetry. Oxidation of the Fe(II) to Fe(III) and
deposition of Fe(III) into the mineral core occurs in the interior of the sphere at ferroxidase
active sites located on H-subunits. Mitochondrial and nuclear forms of ferritin have also
been recently described [6]. Functional assays in yeast indicate that PCBP1 can facilitate
the incorporation of iron into ferritin through a direct protein-protein interaction.
Complementary studies in human cells demonstrate that depletion of PCBP1 impairs the
incorporation of iron into ferritin. Purified recombinant PCBP1 binds Fe(II) with low
micromolar affinity in a 3 Fe:1 polypeptide ratio and can donate iron to ferritin in vitro.
Subsequent studies have identified additional targets for iron delivery through PCBP1, the
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prolyl hydroxylases (PHDs) and asparagyl hydroxylase that modify the alpha subunit of
hypoxia-inducible factor (HIF) [7].
The PHDs are part of a large family of Fe(II)- and 2-oxoglutarate-dependent
dioxygenases [8-10]. Enzymes of this class coordinate a single ferrous ion deep in the
active site via two histidines and a single acidic amino acid residue. A recent study has
shown that PCBP1 is required for the incorporation of iron into PHD2 in cultured human
cells, especially when cells are made transiently iron deficient with iron chelators [7].
Depletion of PCBP1 in cells using siRNA leads to loss of iron incorporation into PHD2 and
loss of PHD activity. PCBP1 directly interacts with PHD2 in cells and a purified PCBP1Fe(II) complex could activate PHD in vitro. PCBP1 is also required to maintain the activity of
FIH1 in cells and an iron-dependent interaction between PCBP1 and FIH1 was
demonstrated in vivo.
PCBP1 (also called hnRNP E1 or α-CP1) is a multifunctional protein and shuttles
between the cytosol and the nucleus to perform its various functions. It acts as a sequence
specific RNA- and DNA-binding protein to regulate the translation or stability of a number of
cellular and viral RNA targets containing C-rich sequences [11-13]. PCBP1 can modulate
gene expression at the transcriptional level and can physically interact with and alter the
fate of other cellular proteins. PCBP1 is a member of a family of four homologous proteins,
which includes PCBP2, PCBP3, and PCBP4. While PCBP1 is an intronless gene, the other
PCBP family members undergo alternative splicing that results in greater diversity in the
expression of PCBPs in mammals. Each member of this gene family contains three hnRNP
K-homology (KH) domains. These are ancient, conserved RNA binding domains that
mediate sequence specific interactions with RNA and single-stranded DNA. Although the
KH domains are highly conserved between PCBP family members, sequences outside
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these domains are much less conserved. PCBP1 exhibits the greatest sequence similarity
(81%) to PCBP2. Both are typically expressed at high levels in cells and they can be found
together in association with RNA and protein targets. Depletion of PCBP2 in mammalian
cells was also associated with defects in the incorporation of iron into PHDs [7]. PCBP3 and
PCBP4 exhibit much more limited levels and patterns of expression, and little is known
about their cellular functions, although both have been demonstrated to bind poly-C RNA.
Overexpression of splice variants of PCBP4 (also called MCG10) can induce apoptosis and
cell cycle arrest in cultured cells [14,15]. PCBP3 has been shown to interact with C-rich
promoter sequences of the mu opioid receptor to influence transcription [16,17].
Here we demonstrate that PCBP2 also functions as an iron chaperone for ferritin in
yeast and mammalian cells and that both PCBP1 and PCBP2 are required to form a stable
complex with ferritin. PCBP3 and PCBP4 also exhibit evidence of iron chaperone activity
when exogenously expressed in yeast and PCBP3 can directly interact with ferritin in cells.
4.3 Experimental Procedures
4.3.1 Yeast strains, plasmids, and media
Saccharomyces cerevisiae W303a (Mata ade2-1 trp1-1 can1-100 leu2-3,112 his3-1,15
ura3-1) was used to construct ferritin H and L/FRE1-HIS3 reporter strains as described [4].
Ferritin H- and L-expressing strains in the YPH499 background were previously described.
Deletion of CCC1 in the YPH499 strains with and without H and L ferritin was performed by
PCR-mediated gene replacement. The KanMx cassette was amplified from genomic DNA
isolated from the YLR220W haploid deletion mutant strain, the PCR product transformed
into the ferritin strains, and G418-resistant clones that also exhibited characteristic iron
sensitivity selected. Strains were tested for correct genome integration by PCR. Open
reading frames corresponding to full-length PCBP1, PCBP2, PCBP4, and FMR1 and the
PCBP3.2 coding sequence were purchased from Open Biosystems and subcloned into the
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yeast expression vector pYX212. To construct a full-length PCBP3, sequences
corresponding to amino acids 201-240 were amplified from rat PCBP3 and subcloned into
pPCBP3.2 by in vivo recombination in yeast. PCBPs were subcloned into pYES2 with
2xFlag, fused in-frame, at the amino terminus. All plasmids were sequenced to confirm
correct inserts. Yeast complete synthetic (SC) medium and defined-iron medium were
prepared as described [18].
4.3.2 Human cell culture
Stable cell lines expressing doxycycline-inducible, Flag-tagged versions of PCBPs
were constructed in the Flp-In T-Rex 293 cell line (Invitrogen) according to the
manufacturer’s instructions. Flag-tagged PCBPs in the pYES2 expression vectors were
PCR amplified and subcloned into pcDNA5/FRT/TO and confirmed by sequencing. The
resulting plasmids and pOG44 were co-transfected into the Flp-In T-Rex 293 cell line and
hygromycin-resistant cells were selected. Stable cell lines and Huh7 cells were maintained
in high glucose Dulbecco’s modified Eagle’s medium containing 5% or 10% fetal bovine
serum, penicillin G 50 U/ml, and streptomycin 50 µg/ml.
4.3.3 Yeast assays
For FRE1-HIS3 reporter assays, congenic W303a strains expressing no ferritin, H
ferritin, L ferritin, or H and L ferritin and containing the FRE1-HIS3 reporter were
transformed with pYX212 or corresponding pPCBPs and transformants plated in serial 10fold dilutions on defined-iron medium, without uracil or without uracil and histidine,
containing 1 mM ferrozine, 10 µM copper sulfate, and 250 µM ferrous ammonium sulfate.
Plates were incubated for three days at 30 °C. For iron-toxicity plate assays, the ccc1Δ
strains expressing no ferritin or H and L ferritin were transformed with pYX212 or pPCBPs
and transformants were plated in serial dilutions on SC medium without uracil,
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supplemented with no extra iron or 5 mM or 6 mM ferrous ammonium sulfate. Plates were
incubated at 30 °C for 3 or 4 days. For
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[Fe]-ferritin iron loading assays in yeast, YPH499

expressing H and L ferritin was transformed with pYX212 or the corresponding pPCBPs.
Transformants were grown from very low density to A600 of 0.5 in SC medium supplemented
with 10 µM
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[Fe]2Cl3 at 2 µCi/mg. Cells were washed, lysed, and analyzed by native gel

electrophoresis and phosphorimaging or Western blotting as previously described [4].
Images were obtained on Typhoon Trio and analyzed using ImageQuant (GE Biosciences).
For immunoprecipitations in yeast, W303a was co-transformed with pYX212 or pPCBP1
and pYES2-Flag-PCBP2, pYES2-Flag-PCBP3, or pYES2-Flag-PCBP4 and pGEV [19].
Transformants were grown in SC medium and expression of Flag-PCBPs induced with 1
µM β-estradiol for 4 hrs. Yeast cellular proteins were extracted by glass bead lysis with 50
mM Tris-HCl (pH 7.4), 40 mM KCl, 1 mM DTT, and complete protease inhibitor (Roche).
Protein extracts were clarified by centrifugation and 1 mg of extract was subjected to
immunoprecipitation using M2 anti-Flag antibody (Sigma) on protein G Dynabeads
(Invitrogen). Samples were eluted in 2x LDS buffer and subjected to Western blotting using
anti-Flag (1:5,000) and anti-PCBP1 (1:10,000). Anti-mouse and anti-chicken secondary
antibodies (LiCor) were conjugated with infra-red dyes (680 and 800 nm, respectively) and
used at 1:10,000. Fluorescent images were collected using the Odyssey system (LiCor).
4.3.4 Real-time PCR
Yeast transformed with pPCBP plasmids were grown in SC medium from very low
density to mid-log phase and harvested at A600 of 0.7. RNA was extracted and real-time
PCR

performed

as

described

[20].

Primers

to

amplify

FIT2

were

5’-

TTTGACAAACGGTTCAGGTTCA-3’ and 5’-TGATTCGACGGCTTGAGTGA-3’ and for FRE2
were

5’-GACGTCCATCTTGAGCGCTAT-3’

and

5’-GTCTTTGCAGGTGATGCTCTTG

3’.
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Quantitative real-time PCR on human cell RNA was performed as described [7] using the
double-stranded DNA dye SYBR Green (Applied Biosystems) on an ABI 7500 system
according to the manufacturer’s protocols.
4.3.5 Electrophoretic mobility shift assays
A yeast pep4Δ strain was transformed with pYES2 and pYES2 Flag-PCBP1, FlagPCBP2, Flag-PCBP3, Flag-PCBP3.2, and Flag-PCBP4. Transformants were grown on SC
raffinose medium and induced with 0.2% galactose for 4 hrs prior to harvesting. Cells were
subjected to glass bead lysis in binding buffer (Tris 50 mM pH 7.4, NaCl 150 mM) plus DTT
1 mM and protease inhibitor tablet (EDTA-free) and lysates were analyzed by Western
blotting with anti-Flag antibody. For oligonucleotide binding, the poly-C probe (5’CCCCACCCCTCTTCCCCCCACCCC-3’) [21] was end-labeled with [γ-32P]ATP using T4
polynucleotide kinase. Assays contained 1 µg of yeast lysate and poly-C probe (100nM) in
binding buffer with or without unlabeled poly-C probe (10 µM) as specific competitor or 10
µM non-specific competitor from the CMV 3’ UTR (5’-CGCAAATGGGCGGTAGGCGTG-3’).
For determination of binding constants, labeled probed was added at 0.15 nM to 50 nM.
Binding reactions were separated on 6% polyacrylamide DNA gels (Invitrogen) and
analyzed by phosphorimaging. Binding constants were calculated by non-linear regression
analysis using Prism5.0 (Graphpad).
4.3.6 Human cell assays
PCBP1 and PCBP2 were depleted in Huh7 cells by transfection of siRNA (Invitrogen)
and

55

[Fe] loading into ferritin measured as described [4]. Ferritin levels in Huh7 cells were

measured by enzyme-linked immunosorbent assay (Bio-Quant) as described. For
immunoprecipitations, PCBP and ferritin expression were induced in stable cell lines by
overnight treatment with doxycycline 1 µg/ml and ferric ammonium citrate 100 µg/ml. Cells
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were harvested and lysed in 0.1% Igepal-CA 630, 100 mM Tris-HCl pH 8.0, 150 mM NaCl,
5% Glycerol, 1 mM DTT, EDTA-Free Protease Inhibitor. Cleared lysates were subjected to
immunoprecipitation with anti-ferritin antibody (Sigma) and protein G sepharose. Immune
complexes and whole cell extracts were analyzed by Western blotting using anti-Flag
(1:10,000), anti-ferritin (1:5000), anti-PCBP1 (1:10,000), anti-PCBP2 (Novus, 1:500), or
anti-tubulin (1:5000) and detected using horseradish peroxidase-conjugated secondary
antibodies.
4.3.7 Isothermal titration calorimetry
Recombinant PCBP1 and PCBP2 were purified and subjected to isothermal titration
Calorimetry [4]. PCBP1 (440 µM) and PCBP2 (300 µM) was incubated anaerobically with 3
molar equivalents of Fe(II) for ~45 minutes before loading into the ITC syringe. Apoferritin
from equine spleen (Sigma Aldrich) was argon purged and brought to a final concentration
of 3 µM before loading into the ITC cell. Both the proteins and the Fe(II) solution were
prepared in buffer containing 50mM Tris, 150mM Nacl, pH 7.6. ITC was conducted at 25
°C on a MicroCal VP-ITC instrument (MicroCal Inc.,Northampton, MA) while maintaining a
constant stirring speed of 416 rpm. Titrates of Fe(II) alone, Fe(II)-PCBP1 or Fe(II)-PCBP2
were injected into ferritin in 10 µl aliquots giving rise to an exothermic profile in each case. A
total of 29 injections were performed with a spacing of 300 s (600 s for PCBP1-ferritin)
between injections to allow for the DT signal to return to the baseline before every new
injection. Origin 7.0 software package supplied my MicroCal was used to analyze and fit the
raw isotherm. All data were best fit with a two binding site model.

76
4.4 Results
4.4.1 Delivery of iron to ferritin via PCBP2 in yeast
We tested whether PCBP2 could act as an iron chaperone for human ferritin in yeast.
To accomplish this, we used yeast strains that convert from histidine auxotrophy to histidine
prototrophy when cytosolic iron is diverted into exogenously expressed human ferritin [4].
Fungi, such as Saccharomyces cerevisiae, do not express ferritins. We constructed yeast
strains in which human H ferritin, human L ferritin, or both are stably integrated into the
genome in a single copy under the control of the strong constitutive PGK1 promoter. These
strains express ferritins and assemble the peptides into multimeric complexes similar to
those of native human ferritins, except that they contain only small amounts of iron. These
strains were further modified to express an iron-dependent reporter. This reporter construct
contains the HIS3 coding sequence under the control of the iron-regulated FRE1 promoter.
After integration into the genome, these strains exhibit histidine auxotrophy (FRE1-HIS3 off)
under iron-sufficient conditions, but switch to histidine prototrophy (FRE1-HIS3 on) under
iron-deficient conditions or when cytosolic iron is diverted into ferritin.
Previously, we demonstrated that expression of PCBP1 could activate the FRE1-HIS3
reporter, especially when cells also expressed H and L ferritin [4]. To test whether PCBP2
could independently act as an iron chaperone for ferritin, we transformed the ferritin reporter
strains with plasmids containing PCBP1, PCBP2, or the empty vector and plated them in
serial dilutions on medium with and without histidine (Fig. 4.1A). Expression of ferritins with
the empty vector did not activate the reporter and the strains did not grow on medium
lacking histidine (-Ura-His, right panel). In contrast, expression of PCBP1 or PCBP2 in a
strain without ferritin, or a strain expressing only L ferritin, weakly activated the reporter and
resulted in a small amount of growth on the plates lacking histidine. Expression of PCBP1
or PCBP2 in strains expressing H ferritin or H and L ferritin more strongly activated the
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reporter and resulted in a larger amount of growth on the plates lacking histidine. Only H
ferritin manifests the ferroxidase activity that is required for incorporation of Fe(II) into the
mineral core as Fe(III); thus, requirement of H ferritin for full activation of the reporter is
consistent with the incorporation of cytosolic iron into the mineral core. PCBP1 and PCBP2
exhibited a similar requirement for the co-expression of H ferritin for full activation of the
reporter.
We directly tested whether co-expression of PCBP2 with H and L ferritin could affect
the amount of iron incorporated into ferritin in vivo. Yeast expressing H and L ferritin were
transformed with plasmids containing PCBP1, PCBP2, or the empty vector. These
transformants were grown in medium containing
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[Fe]Cl3 and the ferritin in lysates was

examined by native gel electrophoresis and autoradiography (Fig. 4.1B and C). Under these
conditions,
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Fe-ferritin is the only species detectable by autoradiography. Strains

expressing PCBP1 or PCBP2 exhibited a 2-fold increase in the amount of iron loaded into
ferritin, and this increase was not due to changes in the level of ferritin protein in the cell
(Fig. 4.1B, lower panel). These data indicated that, when expressed in yeast, PCBP2 was
similar to PCBP1 in its capacity to enhance iron loading into ferritin.
4.4.2 Loss of ferritin iron loading in mammalian cells lacking PCBP2
Previously, we demonstrated that depletion of PCBP1 in Huh7 cells using siRNA
resulted in a loss of iron loading into ferritin [4]. We tested whether Huh7 cells depleted of
PCBP2 exhibited similar defects in ferritin iron loading by transfecting cells with siRNAs
directed against PCBP1, PCBP2, PCBP1 and 2, or a non-targeting control siRNA. Cells
were then incubated with
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[Fe]Cl3 and the amount of iron incorporated into endogenously

expressed ferritin was measured by non-denaturing electrophoresis and autoradiography
(Fig. 4.2A). Depletion of PCBP1, PCBP2, or both PCBP1 and PCBP2 together led to similar
reductions in iron incorporation. Again, the differences in ferritin iron loading were not due to
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Figure 4.1 PCBP2-mediated delivery of iron to ferritin in yeast. A. Activation of irondependent reporter in yeast expressing PCBP1 and PCBP2 with H ferritin. Congenic yeast
strains (W303a background) containing the FeRE/HIS3 reporter and either no ferritin (-),
human H ferritin (H), human L ferritin (L), or both H and L ferritin (H/L) were transformed
with pYX212 (vector), pPCBP1 (PCBP1), or pPCBP2 (PCBP2). Transformants were
plated in serial 10-fold dilutions on defined-iron medium containing 1mM ferrozine and 250
µM iron but lacking either uracil (-Ura) or lacking uracil and histidine (-Ura-His). Plates
were incubated at 30° C for three days. Activation of the FeRE/HIS3 reporter is indicated
by growth on –Ura-His medium. B and C. Enhanced incorporation of 55Fe into ferritin in
yeast expressing PCBP1 and PCBP2. A yeast strain expressing human H and L ferritin
was transformed with pYX212, pPCBP1 or pPCBP2. Transformants were grown in SC
medium supplemented with 10 µM 55[Fe]Cl3. Cell lysates were subjected to native PAGE
followed by phosphorimaging (55Fe ferritin, upper panel in B) or denaturing PAGE followed
by Western blotting with anti-ferritin antibody (ferritin, lower panel in B). Duplicate samples
from each culture were loaded. Ferritin was the only radiolabeled species detected by
phosphorimaging. C. Quantitation of data in B. 55[Fe]-ferritin/ferritin protein ratios were
expressed as percentage of vector control. Experiments were replicated 3 or 4 times.
Error bars depict SEM, **indicates p<0.002.

79
changes in the levels of total ferritin protein (Fig. 4.2B). We confirmed that siRNA
treatments resulted in depletion of PCBP mRNAs by real-time PCR (Fig. 4.2C). These data
suggested that both PCBP1 and PCBP2 were independently required for efficient delivery
of iron to ferritin in Huh7 cells.
4.4.3 Binding of ferritin to both PCBP1 and PCBP2 in mammalian cells
Metallochaperones are proposed to function through metal-facilitated, direct proteinprotein interactions. PCBP1 was demonstrated to physically interact with ferritin in vivo
when both were exogenously expressed in yeast cells [4]. To examine whether PCBP1 or
PCBP2 could interact with ferritin in mammalian cells, we constructed cells lines that stably
expressed epitope-tagged versions of PCBP1 and PCBP2 under the control of a
tetracycline-regulatable promoter (Fig. 4.3A). These cell lines offered two advantages. First,
both cell lines expressed their respective Flag-tagged PCBP at a level similar to the
endogenously expressed protein (Fig. 4.3A, right panels). Because high levels of
overexpression can lead to non-native protein-protein interactions, these lines avoided this
type of artifact. Second, the use of epitope-tagged PCBPs allowed for quantitative
comparisons of PCBP interactions with ferritin by co-immunoprecipitation (Fig. 4.3B). Cell
lines were treated with doxycycline to induce PCBP expression and with FeCl3 to induce
ferritin expression. Lysates were subjected to immunoprecipitation with or without antiferritin antibodies and immune complexes were analyzed by Western blotting. Flag-PCBP1
was
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immunoprecipitates using lower amounts of cell extract (Fig. 4.3B, left panel), it was readily
detected when larger quantities of lysate were subjected to immunoprecipitation (Fig. 4.3B,
right panel). Again, no Flag-PCBP2 was detected in control immunoprecipitates. Although
this requirement for more lysate might suggest that the affinity of the ferritin interaction is
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Figure 4.2. PCBP2-mediated delivery of iron to ferritin in mammalian cells. A.
Decreased ferritin iron loading in Huh7 cells depleted of PCBP1 and PCBP2. Huh7 cells
were transfected with non-targeting control, PCBP1, PCBP2, or PCBP1 and 2 siRNAs.
Cells were labeled overnight with 55[Fe]Cl3 and lysates subjected to native-PAGE and
phosphorimaging. Experiments were replicated three times. B. Total ferritin protein in Huh7
cells lacking PCBP1 and PCBP2. Ferritin protein was detected in lysates from A using
ELISA. C. Efficiency of independent siRNAs in depleting PCBP1 and PCBP2. Huh7 cells
transfected with the indicated siRNAs were analyzed by real-time PCR. Samples were
analyzed in triplicate and expressed as a % of control. Error bars indicate SEM.
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lower for PCBP2 than for PCBP1, Flag-PCBP2 was also expressed at lower levels than
Flag-PCBP1 in these cell lines (Fig. 4.3C).
4.4.4 Requirement for both PCBP1 and PCBP2 in ferritin complex formation
Our data indicated that PCBP1 and PCBP2 were both independently required for
efficient ferritin-iron loading in human cells. To test this mechanistically, we quantitatively
examined the formation of PCBP-ferritin complexes when one of the PCBP components
was depleted by siRNA. We treated the Flag-PCBP1 cell line with non-targeting siRNA or
siRNA against PCBP2. When ferritin was immunoprecipitated, cells lacking PCBP2
exhibited greatly reduced amounts of Flag-PCBP1 in the anti-ferritin immune complexes
(Fig. 4.3D), even though similar amounts of ferritin were precipitated and levels of FlagPCBP1 were similar in both lysates (Fig. 4.3F). In a reciprocal experiment, Flag-PCBP2
cells were depleted of PCBP1 and ferritin was immunoprecipitated. Again, the amount of
Flag-PCBP2 that co-precipitated with ferritin was greatly reduced in cells lacking PCBP1
(Fig. 4.3E), even though Flag-PCBP2 was present at the same level in both lysates (Fig.
4.3F). These data suggest that both PCBP1 and PCBP2 are required to form a stable
complex with ferritin.
4.4.5 High-affinity binding of Fe-PCBP1 and Fe-PCBP2 to ferritin in vitro
To further characterize the interactions of PCBP1 and PCBP2 with ferritin, we used
isothermal titration calorimetry (ITC) to directly measure the binding of individual PCBPs
with ferritin. ITC is a quantitative method of analyzing the thermodynamic properties of a
ligand binding reaction. By measuring the heat evolved in a binding reaction, the binding
constants, stoichiometries, entropies, and enthalpies may be determined. Both PCBP1 and
PCBP2 bind ferrous iron with low micromolar affinity, with PCBP1 binding in a 3:1
stoichiometric ratio and PCBP2 exhibiting a higher stoichiometry [4] and manuscript in
preparation). Titration of Fe(II) into solutions of equine spleen apo-ferritin under anaerobic
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Figure 4.3. Co-immunoprecipitation of epitope-tagged PCBP1 and PCBP2 with
ferritin. A. Construction of cell lines inducibly expressing Flag-PCBP1 and Flag-PCBP2 at
levels similar to endogenous PCBP1 and 2. T-Rex 293 cells containing integrated copies
of empty vector, Flag-PCBP1, and Flag-PCBP2 under the control of a tetracyclineregulatable promoter were untreated or treated with 1 µg/ml doxycycline for 36 hrs.
Lysates were subjected to Western blotting with anti-Flag antibody (left panel), anti-PCBP1
(center panel), and anti-PCBP2 (right panel) and anti-tubulin. Arrow indicates migration of
endogenous PCBP. B. Detection of Flag-PCBP1 and Flag-PCBP2 in immunoprecipitates
of ferritin. Cell lines were treated as in A with the addition of 100 µg/ml ferric citrate for 18
hrs. Lysates were subjected to immunoprecipitation with anti-ferritin antibody or protein A
beads alone and immune complexes analyzed by Western blotting with anti-Flag or antiferritin antibodies, as indicated. Coimmunoprecipitation of Flag-PCBP2 was only detected
when 3 mg of lysate was used. C. Detection of Flag-PCBP1, Flag-PCBP2, and ferritin in
whole cell lysates. Whole cell lysates used in B were subjected to Western blot analysis as
indicated. IB denotes antibody used for immunoblotting.
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conditions produced negative peaks in the raw thermogram, indicating iron binding to ferritin
in an exothermic manner (Fig. 4.4A, upper panel). Integration of the area within the titration
peaks of the raw thermogram yielded the processed spectrum (Fig. 4.4A, lower panel).
Non-linear regression analysis indicated that data best fit a two-site binding model and that
iron bound to ferritin with a Kd1 of 5.6 µM in a 10:1 stoichiometry at the higher-affinity sites
(Table 4.1). These data were similar to those previously published [22]. Next, purified
PCBP1 or PCBP2 was anaerobically loaded with Fe(II) in a 3:1 ratio and titrated into apoferritin (Fig. 4.4B and C). Again, negative peaks in the raw thermograms indicated Fe-PCBP
binding to ferritin in an exothermic reaction. Analysis of the integrated thermograms,
however, indicated that Fe-PCBP1 and Fe-PCBP2 bound to ferritin with affinities that were
30- and 20-fold higher, respectively, than the affinity of Fe(II) alone. Multiple molar
equivalents of the Fe-PCBPs bound to ferritin polymers, consistent with the known structure
of ferritin, which contains eight iron-binding pores formed at the three-fold axes of
symmetry. PCBPs did not show significant interactions with ferritin in the absence of Fe(II)
(not shown), indicating that iron facilitated the protein-protein interaction, possibly through
the formation of PCBP-Fe-ferritin intermediates. These in vitro interactions of Fe-PCBP1
and Fe-PCBP2 with ferritin are consistent with the function of both PCBP1 and PCBP2 as
iron chaperones in vivo.
4.4.6 Low or absent expression of paralogs of PCBP1 and PCBP2 in cultured human
cells
PCBP1 and PCBP2 are part of a multi-gene family that includes PCBP3, PCBP4,
and the more distantly related hnRNP K [12]. All members contain a similar domain
structure, which includes three highly conserved KH domains. Two of the KH domains are
near the amino terminus and are separated from the third, C-terminal KH domain by a
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Figure 4.4 Binding of Fe-PCBP1 and Fe-PCBP2 to ferritin in vitro. ITC of (A) Fe(II) into
ferritin (B) Fe(II)-PCBP1 into ferritin (C) Fe(II)-PCBP2 into ferritin. Anaerobically prepared
Fe(II) and Fe(II)-PCBP in 3:1 ratios were titrated into equine spleen ferritin. Raw isotherm of
heat released per injection (top) and calculated total heat evolved per injection (bottom) is
shown.

Table 4.1 Binding affinities and stoichiometries of Fe-PCBP1 and Fe-PCBP2 for ferritin

Sample

N1

KD1 (µM)

N2

KD2 (µM)

Fe(II) + Ferritin

10.4 ± 0.8

5.6 ± 3.0

65.9 ± 12.1

47.8 ± 45.7

Fe-PCBP1 +
Ferritin

9.5 ± 0.9

0.2 ± 0.1

95.2 ± 12.4

5.3 ± 5.0

Fe-PCBP1 +
Ferritin

4.0 ± 1.2

0.3 ± 0.1

74.0 ± 8.9

2.1 ± 0.6
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region of low homology. PCBP3 is 66% identical to PCBP1 and PCBP4 is 40% identical to
PCBP1. Although PCBP1 and PCBP2 are abundantly expressed in all human tissues,
PCBP3 and PCBP4 are expressed in many fewer tissues and at much lower levels. We
measured the expression levels of PCBPs in HEK293 and Huh7 cells using real-time PCR
and found that, as previously observed, transcripts for PCBP1 and PCBP2 were very
abundant while transcripts for PCBP3 and PCBP4 were detectable, but present at
exceedingly low levels (Fig. 4.5). Thus we were unable to study endogenous PCBP3 or
PCBP4 in cultured cells.
4.4.7 Differential activation of the iron deficiency response in yeast expressing
PCBP3 and PCBP4
To examine the function of PCBP3 and PCBP4 and to compare their functions to
PCBPs 1 and 2, we subcloned the open reading frames of PCBP3 and PCBP4 into yeast
expression vectors and transformed the resulting plasmids into the ferritin reporter strains
as in Figure 4.1A, above. We also examined a naturally occurring splice variant of PCBP3,
called PCBP3.2, which lacks a 26 amino acid sequence located between the second and
third KH domains. As a control, we examined an additional KH domain protein from outside
the PCBP family. FMR1 (fragile X mental retardation 1) encodes an RNA-binding protein
with 2 tandem KH domains [23]; it is not known to play a role in metal metabolism. These
transformants were plated on medium with and without histidine as in Figure 4.1A (Fig. 4.6).
Similar to PCBP1 and 2, strains expressing PCBP3 and either no ferritin or L ferritin
exhibited slow growth on medium without histidine, indicating weak activation of the FRE1HIS3 reporter. In contrast, strains expressing PCBP3 with H ferritin or H and L ferritin grew
well on medium without histidine, indicating strong activation of the reporter. These data
indicated that PCBP3 activated the iron deficiency response in yeast and that PCBP3
genetically interacted with ferritin. A similar examination of PCBP3.2 demonstrated only a
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Figure 4.5 Very low expression of PCBP3 and PCBP4 in cultured cells. Hek293 (left)
and Huh7 (right) cells were harvested and analyzed by real-time PCR using primers for
PCBP1, PCBP2, PCBP3, PCBP4, and actin. Transcript abundance is expressed as a % of
actin mRNA. All 5 transcripts were detected. Error bars indicate SEM.
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Figure 4.6 Activation of iron-dependent reporter in yeast expressing H ferritin and
PCBP3 or PCBP4. Yeast strains (W303a background) expressing human ferritins were
transformed with pYX212 (Vector), pPCBP3, pPCBP3.2, pPCBP4, and pFMR1.
Transformants were plated on defined-iron medium lacking uracil (-Ura) or lacking uracil
and histidine (-Ura –His) as in Figure 4.6 A, above. Rare, fast-growing colonies on a
background of slow-growing colonies represent spontaneously-occurring suppressor
mutants.
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very slight increase in activation of the reporter when compared to the vector-transformed
strains, although growth in the H ferritin-expressing strains was slightly greater than in the
strains without H ferritin. These data suggested that the effects of PCBP3.2 on yeast iron
were much smaller than those of the other PCBPs tested.
Yeast expressing PCBP4 exhibited a different pattern of growth in the reporter strains
than the other PCBPs. Growth was rapid and the FRE1-HIS3 reporter was strongly
activated when PCBP4 was expressed. Furthermore, similar growth was observed in strains
with and without H ferritin, suggesting a lack of genetic interaction with ferritin. Yeast strains
expressing FMR1 exhibited essentially no growth above vector control levels on medium
without histidine and no genetic interaction with ferritin. These data indicated that
expression of KH domains alone was not sufficient to activate the iron deficiency response
or interact with ferritin. Activation of the FRE1-HIS3 reporter in each strain was dependent
on Aft1, the major iron-dependent transcription factor of yeast, as no transformants
activated the reporter when AFT1 was also deleted (data not shown).
4.4.8 RNA binding activity of epitope-tagged PCBPs expressed in yeast
To confirm that all of the PCBPs expressed in yeast were expressed and folded in an
active form, we constructed plasmids containing Flag-epitope-tagged versions of PCBPs
under the control of the galactose-inducible promoter, transformed the resulting plasmids
into yeast, and examined the proteins by Western blotting and oligonucleotide binding
activity (Fig. 4.7). All of the Flag-tagged strains were expressed at similar levels in yeast
(Fig. 4.7A). Binding activity to a

32

[P]-labeled poly C oligonucleotide probe was measured

using an electrophoretic mobility-shift assay coupled with phosphorimaging (Fig. 4.7B and
C). Vector-transformed yeast lysates exhibited no specific protein-poly C complexes.
Lysates from yeast expressing PCBPs exhibited a single PCBP-poly C complex that was 1)
absent when a 100-fold excess of unlabeled poly C probe was added as a specific
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Figure 4.7 Flag-tagged PCBPs expressed in yeast bind oligonucleotides. A.
Expression of Flag-PCBPs in yeast. A pep4Δ strain was transformed with pYES2 and
pYES2 containing N-terminally 2x Flag-tagged PCBP1, PCBP2, PCBP3, PCBP3.2, and
PCBP4. Transformants were grown on SC raffinose medium and induced with 0.2%
galactose for 4 hrs prior to harvesting. Cell lysates were analyzed by Western blotting with
anti-Flag antibody. A major band from the Coomassie-stained gel is shown as a loading
control. B and C. Specific binding of Flag-PCBPs to a poly C oligonucleotide probe. 32[P]labeled poly-C oligonucleotide probe was mixed with buffer alone (P) or yeast lysates from
A and separated by PAGE. Unlabeled poly-C oligonucleotide and mutated oligonucleotide
at 10-fold molar excesses were added as specific competitor (S) and non-specific
competitor (N), respectively. Large arrow corresponds to specific PCBP-probe complex;
small arrow corresponds to free probe.
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competitor (lanes marked S), but 2) present when a 100-fold excess of control probe was
added as a non-specific competitor (lanes marked N). Each of the PCBPs expressed in
yeast exhibited high-affinity binding to poly C oligonucleotide. Titration of increasing
amounts of probe into the yeast lysates was performed and the individual binding affinities
of the protein-DNA complexes was calculated (Table 4.2). All of the PCBPs exhibited lownanomolar binding affinities, similar to those previously published, with PCBP4 exhibiting a
slightly lower affinity than the other PCBPs [21].
4.4.9 Activation of Aft1-mediated transcription by expression of PCBPs and ferritin
Activation of the FRE1-HIS3 reporter in strains expressing PCBPs and H ferritin
suggested that PCBPs could generally activate the iron deficiency response in yeast. To
more quantitatively measure the activation of Aft1 and to confirm the requirement of ferritin
co-expression, we directly measured the capacity of PCBP and ferritin co-expression to
activate transcription of other Aft1-dependent genes (Fig. 4.8). FRE2 and FIT2 are strongly
transcribed in an Aft1-dependent manner in cells exposed to iron deficiency [24]. We
transformed the wild-type parent strain (YPH499) and the congenic H and L ferritin strain
with plasmids for PCBP1, PCBP2, PCBP3, PCBP4, and FMR1 and the empty vector.
Transformants were grown to mid-log phase in iron-replete, SC medium and individual
mRNA levels were measured using real-time PCR. In the YPH499 strain background,
grown in standard SC medium, expression of FRE2 and FIT2 was relatively low and did not
increase when PCBPs were expressed in the absence of ferritin. Expression of H and L
ferritin without PCBPs did not activate the transcription of FRE2 (Fig. 4.8A), but did activate
transcription of FIT2 (Fig. 4.8B), a gene that is very highly induced by small amounts of iron
deficiency. In both cases, co-expression of ferritin with PCBP1, PCBP2, PCBP3, or PCBP4,
but not FMR1, further activated the transcription of FRE2 and FIT2. These data confirmed
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Table 4.2 Binding affinities of PCBPs expressed in yeast for ploy-C oligonucleotide
PCBP1

PCBP2

PCBP3

PCBP3.2

PCBP4

Kd ± 95% CI

3.37 ±

3.67 ± 0.60

3.13 ± 0.99

2.50 ± 0.15

12.42 ±1.51

(nM)

0.85

r2

0.91

0.97

0.89

0.99

0.98

Figure 4.8 Activation of Aft1-dependent transcription in cells expressing both ferritin
and PCBPs. A yeast strain expressing human H and L ferritin and the congenic parent
strain (YPH499 background) were transformed with pYX212, pPCBP1, pPCBP2, pPCBP3,
pPCBP4 or pFMR1. Transformants were grown in SC –Ura medium to mid-log phase and
cells were collected and analyzed by real-time PCR for Aft1 target genes FRE2 (A) and
FIT2 (B). Transcript levels were expressed as the fold-change over pYX212-transformed
cells (EV) without ferritin. Experiments were replicated three times, error bars indicate SEM.
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that each of the PCBPs could activate the iron deficiency response in yeast and suggested
that ferritin was also required.
4.4.10 PCBP3-mediated ferritin iron loading in yeast
We directly measured the capacity of PCBP3 and PCBP4 to augment iron loading into
ferritin in yeast using the

55

[Fe]Cl3 labeling assay. Yeast expressing H and L ferritin were

transformed with PCBPs and FMR1 and the transformants were labeled with

55

[Fe]Cl3.

Lysates were analyzed by native gel electrophoresis and phosphorimaging or by Western
blotting (Fig. 4.9). When compared to vector-transformed yeast, strains expressing PCBP3
exhibited a 1.8-fold increase in ferritin iron accumulation. Expression of PCBP3.2 or PCBP4
was also associated with increased ferritin iron accumulation, but to a lesser degree than
that of PCBP3. Expression of FMR1 had no effect on ferritin iron accumulation. These data
were consistent with a role for PCBP3 in the delivery of iron to ferritin and a weaker role for
PCBP3.2 and PCBP4.
4.4.11 PCBP4- but not PCBP1-mediated reversal of iron toxicity
Data from Figure 4.6 suggested that PCBP4-mediated activation of the FRE1-HIS3
reporter was ferritin-independent. In contrast, data from Figure 4.8, suggested that PCBP4
was similar to other PCBPs in its requirement for ferritin to activate Aft1-dependent
transcription, and Figure 4.9 suggested that PCBP4 weakly augmented ferritin iron loading.
To clarify the activity of PCBP4, we compared the capacities of PCBP4 and PCBP1 to affect
the iron sensitivity of a strain lacking CCC1. CCC1 encodes a polytopic integral membrane
protein that facilitates the transfer of iron from the cytosol to the lumen of the vacuole in
yeast [25]. The vacuole is the major site of iron storage; strains without Ccc1 are unable to
store excess iron in the vacuole and are sensitive to the toxic effects of iron. We tested
whether PCBP1 or PCBP4, with or without ferritin, could mitigate the toxic effects of iron in
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Figure 4.9 Enhanced incorporation of 55[Fe] into ferritin in yeast expressing PCBP3
and PCBP4. A and B A yeast strain expressing human H and L ferritin was transformed
with pYX212, pPCBP3, pPCBP3.2 or pPCBP4. Transformants were grown in medium
supplemented with 55[Fe]Cl3 and analyzed in duplicates as in Figure 4.1B and C, above.
Experiments were replicated three times, error bars indicate SEM. ** indicates p<0.002, *
indicates p<0.05 when compared to vector.
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the ccc1Δ strain (Fig. 4.10). The ccc1Δ strain grew well on standard medium (no added
iron), but exhibited slow (5 mM) or almost no growth (6 mM) on media with high
concentrations of added iron. Expression of H and L ferritin in this strain did not change this
sensitivity to high concentrations of iron. Surprisingly, expression of PCBP1 in the ccc1Δ
strain resulted in very slow (5 mM) or no growth (6 mM), suggesting it enhanced, rather
than mitigated, the toxic effects of iron. Co-expression of PCBP1 and ferritin slightly
aggravated this effect. In contrast, expression of PCBP4 in the ccc1Δ strain resulted in more
rapid growth on high concentrations of iron, suggesting PCBP4 mitigated the toxic effects of
iron. Co-expression of ferritin with PCBP4 was similar to expression of PCBP4 alone. These
data indicated that PCBP1 and PCBP4 exhibited qualitatively different activities when
expressed in yeast, with PCBP1 increasing the toxicity of iron and PCBP4 protecting
against iron toxicity. Although these genetic data do not reveal a biochemical mechanism
for the differences between PCBP1 and PCBP4, these data clearly indicate that PCBP1 and
PCBP4 function differently in yeast. A possible interpretation of these results is that PCBP1,
perhaps by delivering iron to ferritin, maintains cytosolic iron in a bioavailable pool that is
potentially toxic. PCBP4 may act to bind and sequester iron, thus making it less toxic.
4.4.12 Binding of PCBP3, PCBP3.2, and PCBP4 to ferritin in human cells
Although we could not study the functions of endogenously expressed PCBP3 and
PCBP4 in cultured human cell lines, we could construct cell lines that inducibly expressed
PCBP3 and PCBP4 at levels similar to those of PCBP1 and PCBP2. Cell lines expressing
Flag epitope-tagged PCBP3, PCBP3.2, and PCBP4 were constructed and used to measure
the physical interaction of PCBP3 and PCBP4 with ferritin. Both Flag-PCBP3 and FlagPCBP3.2 were detected in immune complexes precipitated with anti-ferritin antibodies, but
not in precipitates without anti-ferritin antibody (Fig. 4.11A). In contrast, Flag-PCBP4 was
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Figure 4.10 PCBP1 enhancement and PCBP4 mitigation of iron toxicity in a ccc1Δ
yeast strain. Yeast strains expressing no ferritin or human H and L ferritin and deleted for
CCC1 were constructed and transformed with pYX212, pPCBP1, and pPCBP4.
Transformants were plated in serial 10-fold dilutions on SC –Ura medium supplemented
with the indicated amounts of ferrous ammonium sulfate. Plates were incubated at 30 °C
for three days.
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not detected in immunoprecipitates, although all three PCBPs were expressed at similar
levels (Fig. 4.11B). These data indicated that PCBP3 formed a complex with ferritin and
could potentially deliver iron to ferritin in cells. Conversely, these data suggested that
PCBP4 did not form a stable complex with ferritin and was unlikely to act as a ferritin iron
chaperone.
4.4.13 Binding of PCBP2, PCBP3, and PCBP4 to PCBP1 in yeast
Previously, we demonstrated that PCBP2 could be detected in immunoprecipitates of
PCBP1 [7]. To determine whether PCBP3 and PCBP4 could also interact with PCBP1, we
expressed PCBP1 and Flag-tagged versions of PCBP2, PCBP3, and PCBP4 in yeast cells
and examined the co-precipitation of PCBP1 in anti-Flag immunoprecipitates (Fig. 4.11C).
PCBP1 was detected in immune complexes from each of the Flag-PCBP-transformed
strains, but not in yeast transformed with the empty vector (EV) that expressed no FlagPCBP and not in yeast that were not transformed with the pPCBP1 plasmid. All yeast
transformed with pPCBP1 expressed PCBP1 at similar levels (Fig. 4.11D). Thus, PCBP3
and PCBP4 appeared to be similar to PCBP2 in their capacity to interact and form a
complex with PCBP1.
4.5 Discussion
4.5.1 PCBP2 is an iron chaperone for ferritin
Recent studies have only begun to illuminate the roles of PCBP family members in the
delivery of iron to target proteins in the cell. Previously, PCBP1 was shown to act as an iron
chaperone for ferritin in both yeast and mammalian cells. Here we have presented evidence
that PCBP2 is similar to PCBP1 in its capacity to 1) activate the iron deficiency response, 2)
genetically interact with H ferritin, but not L ferritin, and 3) enhance the incorporation of iron
into ferritin when both PCBP2 and ferritin are heterologously expressed in yeast. Similar to
PCBP1, PCBP2 was required for efficient delivery of iron to ferritin in human cells, as
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Figure 4.11 Co-immunoprecipitation of PCBP3, PCBP3.2, and PCBP4 with ferritin in
human cells. A.Ferritin binding to PCBP3 and PCBP3.2 expressed at moderate levels. TRex 293 cells containing stably integrated copies of Flag-PCBP3, Flag-PCBP3.2, and FlagPCBP4 were treated with doxycycline and iron as in Figure 3, above, and subjected to
immunoprecipitation with anti-ferritin antibody. Immune complexes were analyzed by
Western blotting with anti-Flag (IB:FLAG) and anti-ferritin (IB:Ferritin) antibodies. B. PCBPs
expressed at similar levels. Whole cell lysates from A subjected to Western blot analysis as
indicated. C. Ferritin binding to PCBP4 expressed at high levels. T-Rex 293 cells were
transiently transfected with pPCBP1-Flag and pPCBP4-Flag and treated with doxycycline
and iron. Antiferritin immunoprecipitates were analyzed by Western blotting. D. Western
blotting of whole cell lysates shown in C. Arrows indicate migration of full-length PCBP-Flag.
E. Co-immunoprecipitation of PCBP1 with PCBP2, 3, and 4. Wild type yeast were
transformed with pPCBP1 (pP1) or the corresponding empty vector and N-terminally Flagtagged PCBP2 (F-P2), PCBP3 (F-P3), PCBP4 (F-P4), or the empty pYES2 vector (EV) and
pGEV. Transformants were grown on SC –Ura-Leu-His medium to early log phase, then
Flag-PCBP expression induced with β-estradiol for 4 hrs. Lysates were subjected to
immunoprecipitation with anti-Flag antibody and immune complexes analyzed by Western
blotting. F. Equal expression of PCBP1 in all transformants. Whole cell lysates from E
subjected to Western blotting with anti-PCBP1 antibody.
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depletion of PCBP2 by siRNA in Huh7 cells led to impaired incorporation of iron into ferritin.
Both PCBP1 and PCBP2 were co-immunoprecipitated with ferritin in iron-treated HEK293
cells and expression of both PCBP1 and PCBP2 was required for the formation of a stable
PCBP-ferritin complex in cells. These studies suggest that, rather than working
independently as iron chaperones, PCBP1 and PCBP2 form a hetero-oligomeric complex
with ferritin for iron delivery. These studies also highlight the utility of heterologous
expression in budding yeast for the functional analysis of mammalian iron proteins.
ITC studies confirmed that iron-loaded PCBP1 and PCBP2 bound to ferritin in vitro in
multiple molar equivalents with high-nanomolar affinity, far higher that the binding affinity of
Fe(II) alone to ferritin and far higher than the affinity of apo-PCBP for ferritin. The higher
binding affinity of Fe-PCBP for ferritin (compared to Fe alone) offers a thermodynamic
explanation for the observation that the iron chaperones increase the efficiency of iron
loading into ferritin. The finding that multiple molar equivalents of Fe-PCBP can bind to
ferritin mechanistically supports a model in which iron is transferred through a direct proteinprotein interaction that occurs at the pores formed between ferritin subunits. Fe-PCBP1
exhibited a stoichiometry of binding of 9.5 ± 0.9. Iron enters the ferritin core through pores
formed along the three-fold axis of symmetry, of which there are 8 in the ferritin polymer.
Thus the ITC data support a model in which PCBP1 interacts with ferritin at the pores where
iron enters.
The studies presented here and previously published data on the capacity of PCBP1
and PCBP2 to deliver iron to PHDs suggest that the two chaperones also function
cooperatively to deliver iron to PHD. Defects in the delivery of iron to PHDs are observed in
mammalian cells only when levels of PCBP1 or PCBP2 are severely depleted. This
observation suggests the unaffected PCBP paralog in siRNA studies cannot rescue the
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activities of the depleted paralog, even when present in abundance. This was demonstrated
directly when purified, recombinant PCBP1 was shown to restore activity to PHDs in lysates
from cells lacking PCBP1, but not from cells lacking PCBP2 [7]. Both PCBP1 and PCBP2
participate independently in other cellular processes and seem to function as adaptor
proteins that mediate the interactions of single-stranded RNA and DNA with other protein
targets. Some of these interactions may be affected by iron binding, as exogenous iron
chelators can enhance the interactions of PCBP2 with dicer and increase the efficiency of
microRNA processing [26].
4.5.2 PCBP3 and PCBP4 also have iron chaperone activity
The data presented here indicated that, in yeast, PCBP3 behaved identically to PCBP1
and PCBP2. Data from human cells indicated that exogenously expressed PCBP3 coimmunoprecipitated with ferritin and preliminary data suggest that purified recombinant
PCBP3 also binds iron in vitro (data not shown). Thus, PCBP3 could potentially function as
an iron chaperone in human cells. mRNA transcripts for PCBP3 have been detected at very
low levels in many tissues [27]. Exogenously expressed PCBP3 can bind to the promoter
and repress the expression of the mu-opioid receptor gene in mouse neuronal cells and it
has been shown to bind a poly-C oligonucleotide [16,17], but beyond these observations
little is known about the functions of PCBP3 in mammals. We observed that the protein
derived from the alternatively spliced PCBP3.2 had reduced activity in yeast, although it coimmunoprecipitated with ferritin in human cells and bound to poly-C oligonucleotide. These
observations suggest that the alternatively spliced forms of PCBP paralogs may be
functionally different and that the sequences between KH domains two and three have a
role in iron binding or delivery. Further studies will be required to determine whether
PCBP3.2 differs in its capacity to bind iron or whether an analogous mutation in PCBP1 or
PCBP2 has functional consequences.
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PCBP4 behaved differently from PCBP1, PCBP2, and PCBP3 in our yeast assays. The
strong activation of the iron deficiency response suggests that PCBP4 expression lowers
the pool of cytosolic iron sensed by Aft1, likely due to iron binding and sequestration by
PCBP4. The mitigation of the toxic effects of iron in the ccc1Δ strain expressing PCBP4
supports the concept that PCBP4 can bind and sequester iron and that it is functionally
different from the other PCBPs. Our data suggest that PCBP4 does not efficiently deliver
iron to ferritin. First, evidence for a genetic interaction was variable. In the plate assay of
Aft1 activation, performed in the W303a background, no interaction with ferritin was
apparent. In contrast, direct measurements of Aft1 target mRNAs, performed in the YPH499
background, indicated activation was ferritin-dependent. The variable genetic interaction
with ferritin and the relatively lower ferritin iron loading activity suggests that while PCBP4
may bind iron, it may not efficiently deliver it to ferritin. This reduced interaction with ferritin
is supported by the observation in human cells that PCBP4-ferritin interactions were not
detectable when PCBP4 was exogenously expressed at moderate levels. PCBP4 may have
a preference for delivering iron to target enzymes other than ferritin, or it could make iron
available to other PCBPs, as it is found complexed with PCBP1 when co-expressed in yeast
cells. PCBP4 is expressed at significantly elevated levels in neuronal tissues and in
embryonic stem cells, suggesting a role in neuronal development [27]. Whether this role
involves a specialized function in iron delivery remains to be determined, but brain tissue
has a marked sensitivity to perturbations in iron homeostasis and may require slightly
different systems for iron uptake and delivery [28].
4.6 Abbreviations
PCBP-poly C binding protein, HIF-hypoxia-inducible factor, HEK-human embryonic
kidney, PHD-prolylhydroxylase, hnRNP-heterogeneous nuclear ribonucleoprotein, KH-
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hnRNP Khomology, SC-synthetic complete medium, ITC isothermal titration calorimetry,
ELISA-enzyme-linked immunosorbent assay, PAGE-polyacrylamide gel electrophoresis,
EMSA-electrophoretic mobility-shift assay, SEM-standard error of the mean.
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CHAPTER 5
ACTIVATION OF THE HIF PROLYL HYDROXYLASE BY THE IRON CHAPERONES
PCBP1 AND PCBP2
5.0 Prelude
Although we know that cells contain hundreds of metalloproteins, very little is known
about how these metalloproteins acquire their metal ions and how they manage to bind the
right metal cofactors. This leaves a fundamental gap in our understanding of the
mechanism of metal acquisition by metalloproteins. The past decade or so has witnessed a
substantial amount of published work on Fe-S cluster proteins’ activation, and a few on
copper enzymes’ metallation but there are only two papers that have addressed the
mechanisms of non-heme, non-Fe-S cluster iron delivery in mammalian cells. The first was
the finding that PCBPs were required for the delivery of iron to ferritin in yeast and human
cells (discussed in previous chapters of this dissertation). The second is that PCBP1 and, to
a lesser extent, PCBP2 are required for iron delivery to prolyl hydroxylase (PHD) and factor
inhibiting HIF 1 (FIH1) in human cells. The second topic is the central focus of this chapter.
An immediate question that emerged from our initial studies of PCBP and ferritin was
whether there were other cytosolic iron proteins dependent on the PCBPs for metallation.
Our recent data, as discussed in this chapter, indicate that the answer to this question is
yes. PCBP1 and PCBP2 play a role not only in delivering metal to ferritin, but also to the
iron-dependent prolyl hydroxylases (PHDs) and the related family member factor inhibiting
HIF 1 (FIH1), both of which regulate hypoxia inducible factor 1 α (HIF1α). Confirmation that
the PCBPs are involved in iron delivery to PHDs and related family members comes from in
vitro studies of PHD activity in cells lacking PCBP1 or PCBP2. In cell lysates lacking either
of these proteins, there was almost complete loss of PHD activity, which could be fully
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restored with high concentrations of iron. This indicated that the loss of PHD activity was
directly related to the loss of iron incorporation into PHD, caused by the depletion of the
PCBPs. These studies also indicated that both PCBP1 and PCBP2 were necessary for
PHD activity but their roles were non-redundant. Their non-redundant roles was confirmed
by addition of PCBP1-Fe(II) complex to cells lacking either PCBP1 or PCBP2. While the
PCBP1-Fe(II) complex was able to restore activity of PHD in cells lacking PCBP1, the
complex had no effect in cells lacking PCBP2. Thus, PCBP1 and PCBP2 have nonredundant roles in the activation of PHD and they are involved in the metallation of at least
two members of this enzyme family. Similar to almost all non-heme iron enzymes, the
mechanism by which PHDs and FIH1 received iron in their active sites remained unknown,
until the discovery of PCBP1 and 2 as the iron chaperones responsible for this delivery. We
therefore believe that this work is a novel finding and a significant contribution to the field of
metalloproteins.
The results of this work have been published as a paper and are reprinted in this
chapter, since the author of this dissertation was a coauthor of the original published paper.
The author of this dissertation contributed by preparing the proteins PCBP1, PCBP2 and
PHD2 required for these studies. The reference for the published paper is as follows:
Nandal, A., Ruiz, J. C., Subramanian, P., Ghimire-Rijal, S., Sinnamon, R. A., Stemmler, T.
L.,Bruick, R. K., and Philpott C. C. “Activation of the HIF prolyl hydroxylase by the iron
chaperones PCBP1 and PCBP2” Cell Metab., 2011, 14(5): 647-57.
5.1 Summary
Mammalian cells express dozens of iron-containing proteins, yet little is known about
the mechanism of metal ligand incorporation. Human poly (rC) binding protein 1 (PCBP1) is
an iron chaperone that binds iron and delivers it to ferritin, a cytosolic iron storage protein.
We have identified the iron-dependent prolyl hydroxylases (PHDs) and asparaginyl
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hydroxylase (FIH1) that modify hypoxia-inducible factor α (HIFα) as targets of PCBP1.
Depletion of PCBP1 or PCBP2 in cells led to loss of PHD activity, manifested by reduced
prolyl hydroxylation of HIF1α, impaired degradation of HIF1α through the VHL/proteasome
pathway, and accumulation of active HIF1 transcription factor. PHD activity was restored in
vitro by addition of excess Fe(II), or purified Fe-PCBP1, and PCBP1 bound to PHD2 and
FIH1 in vivo. These data indicated that PCBP1 was required for iron incorporation into PHD
and suggest a broad role for PCBP1 and 2 in delivering iron to cytosolic nonheme iron
enzymes.
5.2 Introduction
Mammalian cells express hundreds of metalloproteins. Most contain the abundant
metals iron and zinc, while others contain various trace metals such as copper, manganese,
molybdenum, and cobalt (Waldron et al., 2009). These metals are essential nutrients
because metal cofactors activate enzymes and proteins that perform critical functions in
virtually every major cellular process (Dupont et al., 2010). Several factors complicate
incorporation of the correct metal ion into a metalloprotein. First, the binding sites for
different metals within metalloproteins can be structurally very similar, and incorporation of
the noncognate metal ion is easily achieved in vitro for many of these proteins. Second,
pools of “free” metal ions in cells may be vanishingly small and the metals largely
unavailable, as most zinc and copper ions are tightly bound to cytosolic proteins (Outten
and O'Halloran, 2001). Third, redox-active metals, such as iron and copper ions, can
catalyze the production of damaging reactive oxygen species, and cells must maintain tight
control over these metals in order to use them while simultaneously avoiding their toxic
effects. Fortunately, the majority of metalloproteins receive the correct metal ion in vivo, as
incorporation of the wrong metal ion typically inactivates the protein.
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Although the incorporation of the appropriate metal ion(s) into cellular metalloproteins is
a critical, essential process, the mechanism by which most metalloproteins receive their
specific cofactor is unknown. Some proteins rely on metallochaperones: proteins that
specifically bind metal ions and deliver them to target enzymes and transporters through
direct protein-protein interactions (Rosenzweig, 2002). Metallochaperones delivering nickel
and copper have been described in prokaryotes and eukaryotes, but much less is known
about the delivery of iron and zinc. Frataxin, the protein lacking in the neurodegenerative
disease Friedreich's Ataxia, is a mitochondrial protein that is thought to function as an iron
chaperone for the assembly of iron-sulfur clusters (Stemmler et al., 2010).
More recently, we identified poly (rC) binding protein 1 (PCBP1) as a cytosolic iron
chaperone that delivers iron to ferritin (Shi et al., 2008). In mammals, ferritin is a
heteropolymer consisting of 24 subunits of heavy (H) and light (L) peptides that assemble
into a hollow sphere into which iron is deposited (Crichton, 2009; Hintze and Theil, 2006).
PCBP1 binds Fe(II) with micromolar affinity in a 3 Fe:1 PCBP1 molar ratio. PCBP1 binds
ferritin in vivo and can enhance iron incorporation into ferritin in vitro and in vivo.
Mammalian cells lacking PCBP1 exhibit defects in the incorporation of iron into ferritin as
well as an increase in the labile pool of cytosolic iron and an increase in the iron-mediated
degradation of iron-regulatory protein 2.
PCBP1 (also called α-CP1 or hnRNP E1) has previously been found to function as an
RNA-and DNA- binding protein (Chaudhury et al., 2010; Makeyev and Liebhaber, 2002;
Ostareck-Lederer and Ostareck, 2004). PCBP1 is one member of a family of four
homologous proteins containing three heterogeneous nuclear ribonucleoprotein Khomology (KH) domains, an ancient and conserved RNA binding module. PCBP1, an
intronless gene, likely arose from the retrotransposition of a splice variant of PCBP2 mRNA,
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and became fixed in the genome because it encoded a unique function not shared by the
other PCBPs. PCBP1 and 2 bind to cytosolic and viral RNAs, thereby affecting their
translation or stability. PCBPs also have a role in transcriptional regulation and participate in
several protein-protein interactions.
Numerous cellular proteins require iron for activity. Iron in the form of heme and ironsulfur clusters are cofactors for proteins involved in a host of metabolic and regulatory
functions. Enzymes of the “nonheme” iron families directly coordinate iron ions as cofactors.
These families include the diiron monooxygenases, such as the δ-9-fatty acid desaturase
and the small subunit of ribonucleotide reductase (Shanklin et al., 2009). A second family is
the Fe(II)- and 2-oxoglutarate (2-OG)-dependent dioxygenases (Kaelin and Ratcliffe, 2008;
Loenarz and Schofield, 2008; Ozer and Bruick, 2007). This family is a large, evolutionarily
conserved class of enzymes that can oxidatively modify a variety of substrates. In
mammals, four members of this class regulate the activity of the transcription factors that
control the mammalian response to hypoxia.
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that binds DNA at
specific sites, termed hypoxia response elements (HREs), and activates the expression of
more than 100 genes involved in the adaptation to reduced oxygen levels (Kaelin and
Ratcliffe, 2008; Loenarz and Schofield, 2008; Ozer and Bruick, 2007). Under hypoxic
conditions, the alpha subunit (HIF1α or HIF2α) accumulates and binds to the beta subunit
(HIF1β, also called ARNT) to form the active transcription factor. Under conditions of
normoxia or hyperoxia, HIF1α is hydroxylated on proline residues 402 and 564, which
allows the protein to be recognized by the von Hippel-Lindau tumor suppressor protein
(pVHL), thus targeting HIF1α for ubiquitin-mediated degradation in the proteasome (Ivan et
al., 2001; Jaakkola et al., 2001). Three HIF prolyl hydroxylases, PHD1, 2, and 3 (also called
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HPH-3, -2, and -1 or EGLN2, 1, and 3, respectively) mediate the hydroxylation of proline
residues on HIF1α (Bruick and McKnight, 2001; Epstein et al., 2001), although PHD2 is
responsible for nearly all (>95%) of the activity in cultured cells (Berra et al., 2003). HIFα is
also hydroxylated on Asn803 by an asparaginyl hydroxylase, factor inhibiting HIF (FIH1)
(Hewitson et al., 2002; Lando et al., 2002a). Hydroxylation of Asn803 inhibits the binding of
transcriptional coactivators with HIF1α and represents a second mechanism for inhibition of
HIF activity (Lando et al., 2002b). The activities of the HIF hydroxylases are regulated by
the availability of the cosubstrates, 2-OG and oxygen. Because the hydroxylases exhibit
changes in oxygen binding and activity over the range of oxygen concentrations present in
tissues, these enzymes are hypothesized to function directly as oxygen sensors.
The activities of the HIF hydroxylases may also be regulated by the availability of iron.
HIF hydroxylase activity is stimulated by the addition of Fe(II) in vitro, and, in cultured cells,
activity is inhibited by iron chelators (Kaelin and Ratcliffe, 2008). In mice, HIF2α
accumulates in duodenal enterocytes in response to iron deprivation, which may reflect a
localized decrease in HIF hydroxylase activity (Shah et al., 2009). Cellular factors that
control the incorporation of iron into the HIF hydroxylases are unknown. Here we have
addressed the question of whether PCBP1, or its paralog PCBP2, is involved in the delivery
of iron to the Fe(II)-dependent prolyl and asparaginyl hydroxylases regulating HIF. We
found that iron-deprived cells lacking PCBP1 or PCBP2 exhibited increased levels of
HIF1α, which was due to a decrease in prolyl hydroxylation and VHL-mediated degradation.
The loss of prolyl hydroxylase activity was traced to a decrease in iron loading of the
enzyme, which could be restored with recombinant PCBP1. PCBP1 physically interacted
with PHD2, indicating that PCBP1 likely acts as an iron chaperone for PHD2. Our studies
also suggest a direct role for PCBPs in the activation of the asparaginyl hydroxylase FIH1.
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5.3 Results
5.3.1 Accumulation of Transcriptionally Active HIF1 in Cells Lacking PCBPs
The activity of the iron-dependent PHDs is reflected in the abundance of HIF1α protein.
In Huh7 cells grown under normoxia, PHDs are fully active, and HIF1α from nuclear
extracts was barely detectable (Figure 5.1A, left panel). Overnight treatment (16 hr) of cells
with the iron chelator desferrioxamine B (DFO) inhibited the PHDs and led to a large
accumulation of HIF1α. We examined the effects of PCBP depletion on HIF1α levels in the
absence of DFO treatment by transfecting Huh7 cells with small interfering RNAs (siRNAs)
directed against PCBP1 and 2 and with control siRNA. Depletion of PCBP1 or PCBP1 and
2 together resulted in a 2-fold to 3-fold increase in HIF1α protein when compared to the
cells treated with control siRNA, without a significant change in HIF1α levels in cells treated
with siRNA against PCBP2 (Figures 5.1A, right panel, and 5.1B).
We tested whether the increase in HIF1α protein was associated with an increase in
HIF1α transcriptional activity. A HeLa cell line that contains a stably integrated copy of the
firefly luciferase coding sequence under the control of the HRE exhibits luciferase activity in
proportion to the activity of the HIF transcription factors (Tian et al., 1997). Treatment of this
cell line with iron or untreated cells exhibited very low luciferase activity, while treatment
with DFO for 16 hr led to a 27-fold increase in luciferase activity (Figure 5.1C). This cell line
was then depleted of PCBP1, 2, or both PCBP1 and 2 without DFO treatment. Cells lacking
PCBP1 exhibited a 5-fold increase in luciferase activity, while cells treated with siRNAs for
both PCBP1 and 2 exhibited a 1.6-fold increase in activity when compared to control cells.
Consistent with Figure 5.1A, these data indicated that, in the absence of iron chelation, cells
lacking PCBP1 exhibited both an increase in HIF1α levels and an increase in HIFdependent transcription.
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5.3.2 Increased Effects of PCBP Depletion in Mildly Iron-Deficient Cells
While treatment of Huh7 cells with DFO for 8–14 hr markedly inhibited cellular PHDs, brief
treatments of 2–4 hr produced a small accumulation of HIF1α, suggestive of mild iron
deficiency and partial inhibition of PHD (Figure S5.1C). We hypothesized that cells depleted
of PCBP might show increased sensitivity to mild iron deficiency and briefly treated cells
depleted of PCBPs with DFO, then examined the levels of HIF1α (Figures 5.1D and 5.1E).
When cells subjected to a single transfection of PCBP siRNA were compared to cells
treated with control siRNA, cells depleted of PCBP1 exhibited a 7-fold increase in the level
of HIF1α. Cells depleted of both PCBP1 and 2 exhibited similarly high levels of HIF1α, while
cells lacking only PCBP2 exhibited a variable increase in HIF1α levels. Further depletion of
PCBP2 and PCBP1 and 2 together was achieved by two sequential treatments with siRNA
(Figures 5.1D and 5.1E, lanes marked “x2”), which resulted in 9-fold increases in HIF1α
levels. We measured the effects of siRNA treatment on PCBPs by western blotting and by
quantitative real-time PCR, and confirmed that our siRNA transfections produced depletion
of PCBP1 and 2 in Huh7 cells, although simultaneous depletion of PCBP1 and 2 was less
efficient than depleting them individually (Figures 5.1F, S5.1A, and S5.1B). To rule out offtarget effects of the siRNAs, we transfected Huh7 cells with alternative siRNAs directed
against other regions of the PCBP mRNAs and found that these siRNAs also increased
HIFα(Figures S5.1E and S5.1F). Although plasmid transfection efficiency of cells previously
treated with siRNA was low, the effects of PCBP1 depletion could be partially rescued by
expression of a mutant PCBP1 not targeted by the siRNA (Figure S5.1D).
5.3.3 Increased Half-Life of HIF1 in PCBP-Depleted Cells
The elevated levels of HIF1α in cells lacking PCBPs could be due to either an increase in
HIF1α gene expression or a decreased rate of HIF1 protein degradation. We examined the
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Figure 5.1 Accumulation of HIF1α and Increased HIF Activity in Cells Depleted of
PCBPs. (A–F) Elevation of HIF1α protein levels in cells lacking PCBP1 and PCBP2 (A and
D). PCBP1 and PCBP2 were depleted in Huh7 cells using one (D, center panel) or two (A
and D, right panel) transfections of siRNA. Cells were then treated with no DFO or 100 µM
DFO for 2 hr or 16 hr, as indicated. Nuclear extracts were subjected to SDS-PAGE and
western blotting using anti-HIF1α and anti-CREB as a loading control (A and D). HIF1α
blots were quantitated and expressed as a percentage of control-treated cells, ± SEM (B
and E). Increased HIF1α transcriptional activity after depletion of PCBP1 (C). A HeLa cell
line containing 3XHRE upstream of a luciferase reporter gene was treated with 20 µM FeCl3
or 100 µM DFO, or depleted of PCBP1, PCBP2, or both in the absence of DFO. After 3
days, cells were harvested and lysed, and luciferase activity was measured. The
experiment was replicated thrice, error bars indicate SEM. * indicates p < 0.05.
Confirmation of PCBP1 and PCBP2 depletion by siRNA (F). Cytoplasmic extracts from cells
in (A) were subjected to SDS-PAGE and western blotting using anti-PCBP1 and antiPCBP2. Membranes were reprobed with mouse anti-actin. Molecular weight standards are
in kDa. See also Figure S5.1.
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levels of HIF1α mRNA in cells depleted of PCBPs using real-time PCR (Figure 5.2A).
Changes in HIF1α mRNA levels in PCBP-depleted cells were small and did not account for
the observed changes in protein levels. We next examined the half-life of HIF1α protein in
Huh7 cells depleted of PCBP1 and 2 versus control cells. Cells were treated with DFO for 2
hr, cycloheximide was added to block new protein synthesis, cells were collected at
intervals, and nuclear extracts were examined by western blotting (Figure 5.2B). HIF1α
protein levels were quantitated and the half-life was calculated (Figure 5.2C). Consistent
with previous reports, HIF1α was rapidly degraded in control cells (t1/2 = 8 min), while HIF1α
exhibited much greater stability in cells depleted of PCBP1 and 2 (t1/2 = 50 min), although
the presence of DFO during the cycloheximide incubation may also have contributed to the
stability of HIF1α. These data indicated that the accumulation of HIF1α in cells depleted of
PCBP1 was due to impaired degradation of the protein.
5.3.4 Reduced Hydroxylation of HIF1α in Cells Lacking PCBPs
VHL-mediated degradation of HIF1α is dependent on the hydroxylation of proline residues
402 and 564 on the oxygen-dependent degradation domain of HIF1α (Ivan et al., 2001;
Jaakkola et al., 2001). Cells lacking PCBPs may exhibit impaired degradation of HIFα
because of impaired hydroxylation of these proline residues; therefore, we measured the
hydroxylation of Pro564 in A549 cells lacking PCBPs. A549 cells were selected because
they expressed higher levels of PHD2 mRNA than Huh7 cells (see Figure 5.4A) and HIF1αOH was readily detectable. A549 cells were similar to Huh7 cells in that transfections of
siRNA for PCBP1, 2, and PCBP1 and 2 together also produced markedly elevated levels of
HIF1α in the presence of DFO (Figure S5.2A). Depletion of PCBPs in A549 cells was also
efficient, although again simultaneous depletion of PCBP1 and 2 was less efficient (Figures
5.3D, S2C, and S2D). We measured hydroxylation of Pro564 by blocking proteasome--
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mediated degradation with the inhibitor MG132 and detecting hydroxylated HIF1α using an
antibody that specifically recognizes the hydroxylated form (HIF1α-OH). Brief treatment of
A549 cells with 25 µM DFO did not change HIF1α-OH levels (Figure S2B), and DFO (25
µM) was therefore included in experiments measuring HIF1α-OH levels. Nuclear extracts
were probed for HIF1α-OH, total HIF1α, and CREB (Figures 5.3A and 5.3B). HIF1α-OH
was readily detected in cells treated with no or control siRNA, while cells depleted of
PCBP1 exhibited dramatically reduced levels of HIF1α-OH and cells lacking PCBP2 or
PCBP1 and 2 exhibited moderately reduced HIF1α-OH. The specificity of the antibody for
HIF1α-OH was demonstrated by the absence of signal in untreated cells (−MG132), which
also had no detectable HIF1α, and the absence of signal in cells treated for 16 hr with DFO
alone (+DFO), which had abundant HIF1α. Although treatment with MG132 inhibited the
degradation of HIF1α in all conditions, cells depleted of PCBP1 exhibited a higher level of
total HIF1α. Despite the higher level of total HIF1α, the decrease in HIF1α-OH was still
detected, confirming that depletion of PCBPs was associated with a loss of HIF1α Prolyl
hydroxylation. The activity of the HIF PHDs can be measured in vitro using an assay that
relies on the specific interaction of pVHL with a HIF1α-derived peptide containing
hydroxyproline 564, but not with a peptide containing an unmodified proline (Aprelikova et
al., 2009; Tuckerman et al., 2004). We used HEK293T cell lysates containing PHD to
hydroxylate a HIF1α synthetic peptide corresponding to residues 556–574, which had been
bound to magnetic beads. VHL protein was incubated with the peptide, and the amount of
pVHL captured was measured by western blotting. HEK293T cells were selected because
they expressed more PHD2 than Huh7 cells, and depletion of PCBPs was very efficient with
two sequential transfections of siRNAs (Figures 5.3D and S2F).

115

Figure 5.2 Increase in HIF1α Half-Life in Cells Lacking PCBPs (A) Lack of change in
HIF1α mRNA levels in cells depleted of PCBPs. Huh7 cells were depleted of PCBP1,
PCBP2, or both, untreated or treated with DFO for 2 hr. HIF1α mRNA levels were
measured by real-time PCR and presented as a percentage of actin. Samples were
analyzed in triplicate, and the experiment was repeated thrice. (B and C) Increase in
HIF1α half-life in cells depleted of PCBPs. Huh7 cells were depleted of both PCBP1 and
2, then treated with 25 µM DFO for 2 hr. Cycloheximide was added, and the cells were
lysed at indicated times. HIF1α and CREB were detected as in Figure 5.1B. Blots were
quantitated, HIF1α levels were normalized to CREB and plotted as a percentage of T = 0
levels (C). Error bars indicate SEM.
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Figure 5.3 Impaired HIF1α Hydroxylation and VHL Binding after Depletion of PCBPs
(A) Decrease in hydroxylated HIF1α after depletion of PCBPs. A549 cells were depleted of
PCBP1, PCBP2, or both, then treated with MG132 and 25 µM DFO for 2 hr. Nuclear extracts
were analyzed by western blotting with anti-HIF1α-OH, anti-HIF1α, and anti-CREB.
Untreated cells (-MG132) and cells treated with DFO overnight were used as controls. (B)
Quantitation of HIF1α-OH levels in (A). Error bars indicate SEM. (C) Decrease in pVHL
binding to hydroxylated HIF1α after depletion of PCBPs. HEK293T cells depleted of PCBP1,
PCBP2, or both were treated with 25 µM DFO, and lysates were added to immobilized
HIF1α peptide containing proline 564. Peptides were washed, and HA-pVHL was allowed to
bind to the HIF1α peptide. Bound HA-pVHL was measured by western blotting using antiHA. Hydroxylated synthetic HIF1α peptide (Peptide-OH) was the positive control, and cells
treated overnight with DFO (+DFO) were the negative control. Nuclear extracts of cells
depleted of PCBPs were probed for HIF1α and CREB by western blotting. (D) Confirmation
of PCBP depletion by siRNA. A549 cells or HEK293T cells treated with siRNA were
subjected to SDS-PAGE and western blotting using anti-PCBP1 and anti-PCBP2, then
reprobed for actin. HEK293T cells were sequentially transfected to deplete PCBP1 and
PCBP2. See also Figure S5.2.
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Cells were treated with siRNAs for PCBP1 and 2 and control siRNA, briefly treated with
DFO, then lysed and assayed for PHD activity by the pVHL capture method (Figures 5.3C
and S2E). Cells transfected with no or control siRNA exhibited readily detectable PHD
activity, while cells lacking PCBP1 and 2, individually or in combination, exhibited much
lower levels of activity (38%–13% of Control). The specificity of the hydroxylated peptide for
pVHL capture was confirmed using a hydroxylated synthetic peptide as a positive control
(Peptide-OH) and lysate from cells treated overnight with DFO as a negative control
(+DFO). HEK293T cells lacking either PCBP1, 2, or PCBP1 and 2 exhibited similar losses
of PHD activity. Consistent with this observation, the increase in the total amount of HIF1α
in HEK293T cells lacking PCBP1 and/or 2 was also similar (Figure 5.3C).
5.3.5 Reduced Metallation of PHD2 in Cells Lacking PCBPs
The reduced hydroxylation of HIF1α in cells lacking PCBPs could be explained by
reduced levels of PHD mRNA or protein or by reduced specific activity of the enzyme. We
measured mRNA levels of PHD2 by real-time PCR and found only small differences (less
than 2-fold) between control cells and cells lacking PCBPs in Huh7, A549, or HEK293T cell
lines (Figure 5.4A). PHD2 protein levels did not significantly change in Huh7, HEK293, and
A549 cells after depletion of PCBPs (Figures 5.4B, 5.4C, and 5.5A). These data suggested
that depletion of PCBPs reduced the specific activity of PHD2 rather than affecting protein
levels. The activity of PHD2 is dependent on the incorporation of iron into the enzyme.
Therefore, we measured the amount of iron bound to PHD2 from cells labeled in vivo with
55

[ Fe]. HEK293T cells were depleted of PCBPs, then transiently transfected to overexpress
55

a FLAG-epitope-tagged version of PHD2, and labeled with [ Fe] in the absence of DFO.
PHD2 with its bound iron was recovered by immunoprecipitation and measured by
scintillation counting (Figure 5.4C). The amount of iron bound to PHD2 was reduced by
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78%, 62%, and 73%, respectively, in cells lacking PCBP1, PCBP2, or PCBP1 and 2. There
was no difference in the amount of PHD2 protein immunoprecipitated (Figure 5.4C, top
panel). These data suggested that the loss of PHD activity in cells lacking PCBPs was due
to a failure to incorporate the Fe(II) cofactor.
5.3.6 Restoration of PHD Activity with Iron or Purified PCBP1
We employed a more quantitative assay to further characterize the loss of PHD activity
in cells lacking PCBPs without DFO treatment. Peptides corresponding to residues 556–574
of HIF1α were immobilized, then lysates from A549 cells depleted of PCBPs were
incubated with the peptides in the presence of 2-OG and ascorbate. The amount of
hydroxylation of Pro564 was measured using an antibody that specifically recognized PHD2
that lacks the iron cofactor can be activated in vitro with high concentrations of Fe(II) (Figure
S5.4). We tested whether PHD activity could be restored by treating the PCBP lysates with
Fe(II) in vitro. Lysates from control cells exhibited full PHD activity when assayed with or
without exogenous iron (Figure 5.5B), suggesting that the PHD from these cells was fully
metallated. In contrast, lysates from cells depleted of PCBP1 and PCBP1 and 2 exhibited
virtually no PHD activity in the absence of exogenous iron, but were restored to nearly full
activity upon addition of exogenous iron. These data suggested that the loss of PHD activity
could be fully explained by the absence of the Fe(II) cofactor from the enzyme in the PCBPdepleted lysates. We next tested whether addition of purified, iron-loaded PCBP1 could
restore PHD activity. Purified recombinant PCBP1 (P1) was incubated anaerobically with
Fe(II) and added to lysates from cells depleted of PCBPs. The lysates were then assayed
for PHD activity (Figure 5.5C). Iron-loaded bovine serum albumin (BSA) and unliganded
Fe(II) were used as controls, and the final concentration of iron (10 µM) was the same for all
samples. Purified, iron-loaded PCBP1 was able to restore PHD activity to near control
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Figure 5.4 Decrease in PHD2 Metallation after Depletion of PCBPs (A) Lack of
change in PHD2 transcript levels after depletion of PCBPs. PCBP1, PCBP2, or both were
depleted from Huh7, A549, and HEK293T cells. PHD2 mRNA levels were measured by
real-time PCR and expressed as a percentage of actin. Error bars indicate SEM. (B) Lack
of change in PHD2 protein levels after depletion of PCBPs. PHD2 was detected in Huh7
whole-cell lysates by western blotting. The blot was reprobed for actin. (C) Less iron in
immunoprecipitated PHD2 after depletion of PCBPs. PCBP1, PCBP2, or both were
depleted from HEK293T cells, then cells were transiently transfected with p3xFLAGCMV-PHD2 to overexpress PHD2. Cells were labeled with 55Fe, then PHD2 was detected
by western blotting, or PHD2 with its iron ligands was immunoprecipitated using antiFLAG. Immune complexes were subjected to scintillation counting, and the retained 55Fe
was expressed as a percentage of the 55Fe from control lysates. Nonspecific 55Fe binding
was measured using IPs from mock-transfected cells (average 19% of control) and
subtracted. The experiment was replicated three times. Error bars indicate SEM, *
indicates p < 0.05. See also Figure S5.3.
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Figure 5.5 Requirement of PCBPs for Iron-Dependent PHD Activity (A) Decrease in PHD
activity after depletion of PCBPs. A549 cells were depleted of PCBP1 and PCBP2 by siRNA.
Cells were lysed and assayed for PHD protein (upper panels) and activity in the presence of
10 !M Fe(II). (B) Increased PHD activity after addition of exogenous iron in lysates depleted of
PCBPs. PHD2 activity was measured as in (A) in assays containing the indicated
concentrations of iron. (C) Restoration of PHD activity upon addition of iron-loaded PCBP1
protein to PCBP1-depleted lysates. PHD activity measured as in (A). Purified recombinant
PCBP1 and BSA were loaded with Fe(II) and added to lysates prior to measurement of PHD
activity. Unliganded Fe(II) was used as an additional control, and all assays contained 10 !M
Fe as a final concentration. Activity was expressed as luminescence units. Assays were
performed in triplicate, experiments were replicated four or more times. Error bars represent
SEM. See also Figure S4.
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levels in lysates from cells lacking PCBP1 and to partially restore activity in lysates from
cells lacking PCBP1 and 2. In contrast, addition of iron-loaded PCBP1 to lysates from cells
lacking PCBP2 was no more effective than iron-loaded albumin or iron alone in restoring
PHD activity. These data indicated that iron-loaded PCBP1 could restore PHD activity in
vitro to cells lacking PCBP1, but not to cells lacking only PCBP2. This finding suggested
that PCBP1 and 2 had nonredundant functions and may cooperate in the delivery of iron to
PHD.
5.3.7 In Vivo Interactions between PCBP1 and PHD2
PCBP1 directly binds to ferritin in the process of delivering iron for mineralization, and,
in yeast cells, this interaction is dependent on the presence of iron (Shi et al., 2008). We
examined the in vivo binding of PCBP1 to PHD2 in HEK293T cells by testing for the
presence of PHD2 in immune complexes precipitated using antibodies against PCBP1
(Figure 5.6A). PHD2 was readily detected in immune complexes obtained after
immunoprecipitation

of

PCBP1,

and

no

PCBP1

or

PHD2

was

detected

in

immunoprecipitates using nonspecific IgY as a control antibody. The effects of iron
manipulation on PHD2 binding to PCBP1 were small and not consistently detected. Iron
manipulation had no effect on the total levels of PHD2 or PCBP1 in the whole-cell lysates.
These data indicated a physical interaction between PCBP1 and PHD2.
Our data suggested that both PCBP1 and 2 were involved in the delivery of iron to
PHDs, and that their functions were not redundant. To determine whether PCBP1 and 2
physically interacted, we again immunoprecipitated PCBP1 from HEK293T cells that had
been treated with iron or DFO and tested for the presence of PCBP2 in the immune
complexes (Figure 5.6B). PCBP2 was detected in precipitates of PCBP1, but not in control
precipitates using nonspecific IgY, demonstrating that at least a portion of PCBP1 and
PCBP2 are bound together as a complex in vivo.
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Figure 5.6 Physical Interaction of PCBP1 with PHD2 (A) Coimmunoprecipitation of
endogenous PHD2 with PCBP1. HEK293T cells were treated for 16 hr with 20 µM FeCl3
or 100 !M DFO. PCBP1 was immunoprecipitated using anti-PCBP1 or bulk IgY as a
negative control. Panels on right, immune complexes analyzed by western blotting for
PHD2 and PCBP1. Panels on left, western blots of whole-cell lysates before
immunoprecipitation. (B) Coimmunoprecipitation of PCBP2 with PCBP1. Cell treatment
and immunoprecipitations were carried out as in (A), then immune complexes were
analyzed for PCBP2 and PCBP1.
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5.3.8 Genetic and Physical Interactions of PCBP1 with FIH1
FIH1 is an asparaginyl hydroxylase of the same Fe- and 2-OG-dependent dioxygenase
family as the PHDs, and we questioned whether FIH1, similarly to PHD, also required
PCBPs for Fe-dependent activation. FIH1 hydroxylates a conserved asparagine residue in
the carboxyl-terminal transactivation domains (CADs) of HIF1α and HIF2α (Lando et al.,
2002a; Lando et al., 2002b). This modification does not lead to degradation of the CADs,
but instead prevents the association of transcriptional coactivators with HIF, thereby
blocking the activity of the HIFα CADs. Fusion of the CADs to the Gal4 DNA-binding
domain (GalDBD) permits the measurement of FIH1 hydroxylase activity through the
capacity of FIH1 to inhibit the GalDBD/HIF2α CAD-dependent transcription of a Galresponsive luciferase reporter. HEK293 cells were depleted of PCBPs, then cotransfected
with plasmids expressing GalDBD/HIF2α CAD, wild-type FIH1, and a luciferase reporter
under the control of a Gal4-responsive promoter (5XGRE) (Figure 5.7A). Mutation of
Asn851to Ala in HIF2α blocks hydroxylation of the Asn residue by FIH1, resulting in
constitutive activation of the HIF2α CAD. Therefore, a plasmid containing the Asn851Ala
substitution was also transfected. Cells were not treated with DFO. In cells treated with
control siRNA, FIH1 was fully active, and luciferase activity was very low (Figure 5.7B). In
contrast, control cells expressing the Asn851Ala CAD exhibited 10-fold higher luciferase
activity. Cells depleted of PCBP1 exhibited a 5-fold increase in luciferase activity when
compared to the control, and cells depleted of PCBP1 and 2 exhibited a 3-fold increase in
activity. As with PHD2, depletion of PCBPs had no effect on FIH1 protein levels (Figure
5.7C) and depletion of PCBPs by siRNA was confirmed (Figure S5.5A). Similar to Figures
5.1A and 5.1C, these data suggested that cells lacking PCBP1 had reduced FIH1 activity
even without treatment with DFO.
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Figure 5.7 Genetic and Physical Interactions of PCBP1 with FIH1 (A and B) Loss of
FIH1 activity in cells lacking PCBP1. HEK293 cells were depleted of PCBP1 and 2 with
siRNA, then cotransfected with plasmids encoding the GalDBD/HIF2 CAD or the
Asn851Ala mutant CAD, Gal4-responsive luciferase reporter, control renilla luciferase, and
FIH1. Normalized luciferase activity was expressed as a fold increase over the activity of
control siRNA treated cells. Data are the average of three transfections. Error bars indicate
SEM. (C) Lysates from (A) were subjected to western blotting for FIH1 and reprobed for
actin. (D) Coimmunoprecipitation of FIH1 with PCBP1. HEK293T cells transiently
expressing FIH1-myc-HisA (pFIH1) or untransfected cells (–pFIH1) were treated for 2 hr
with iron and DFO, then PCBP1 was immunoprecipitated as in Figure 6. Whole-cell lysates
and immune complexes were blotted for FIH1 and PCBP1. See also Figure S5.5.
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We tested whether FIH1 was bound to PCBP1 in HEK293 cells overexpressing FIH1 by
immunoprecipitating

endogenous

PCBP1

and

examining

immune

complexes

for

coprecipitation of FIH1 (Figures 5.7D and S5D). Similar to PHD2, FIH1 was detectable in
immune complexes containing PCBP1, but not in control IgY immunoprecipitations. Unlike
PHD2, only immune complexes from cells treated with iron contained significant
coprecipitated FIH1. The migration of FIH1 as a doublet was frequently observed in lysates
from transfected and untransfected cells (Figure S5.5C). Coimmunoprecipitation of
endogenous FIH1 with PCBP1 was also detected in cells treated with iron (Figures 5.7D
andS5D, right panels, “– pFIH1”). These data suggested that PCBP1 also acted as an iron
chaperone for FIH1.
5.4 Discussion
Although most nonheme iron enzymes receive their metal cofactor through an unknown
mechanism, our studies indicated that PHDs and FIH1, the prolyl and asparagyl
hydroxylases that modify HIF1α, depend on members of the PCBP family of iron
chaperones/RNA-binding proteins to incorporate Fe(II) into their active sites, especially in
cells briefly exposed to iron limitation. Cells lacking PCBP1 or 2 exhibited reduced PHD
activity, which resulted in less prolyl hydroxylation of HIF1α, less degradation of HIF1α
through the pVHL-proteasome pathway, and accumulation of HIF1α protein. Because the
loss of PHD activity was associated with a loss of the iron cofactor, PCBP1 must be
involved in the metallation of PHD. Previously, we have shown that depletion of PCBP1 in
Huh7 cells does not result in a loss of iron uptake activity and is associated with an increase
in the labile iron pool (Shi et al., 2008); therefore, cellular iron for metallation of PHD must
be present. We found that iron-loaded PCBP1 specifically restored activity to inactive PHD
in vitro and that PCBP1 and PHD2 physically interacted in vivo by coimmunoprecipitation.
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Thus, we propose that PCBP1 is an iron chaperone for PHD as well as for ferritin.
We have previously shown that expression of PCBP2 in yeast cells containing human
ferritin activates the iron deficiency response of yeast, indicating that PCBP2 can disrupt
iron homeostasis in yeast (Shi et al., 2008). Preliminary data indicate that PCBP2 can bind
both iron and ferritin, suggesting that PCBP2 can also function as an iron chaperone (A.N.,
T.L.S., and C.C.P., unpublished data). Here, we show that cells lacking PCBP2 also exhibit
loss of PHD activity and accumulation of HIF1α, indicating that PCBP2 is also an iron
chaperone for PHDs. The loss of FIH1 activity in cells lacking PCBP1 and the binding of
PCBP1 to FIH1 in vivo suggest that PCBP1 acts as an iron chaperone for this second type
of Fe- and 2-OG-dependent oxygenase. The role of PCBP2 in the activation of FIH1 is not
yet clear.
In these studies, PCBP1 and 2 were required in cultured cells for hydroxylation and
degradation of HIF1α, but the effects were much greater in cells transiently exposed to iron
limitation. In the absence of DFO, the effect of PCBP1 depletion on HIF1α degradation was
reproducible but small, and no effect of PCBP2 depletion was observed. In contrast, in vitro
measurement of PHD activity in lysates from A549 cells not treated with DFO indicated that
depletion of PCBP1 or 2 resulted in a dramatic decrease in activity. There are multiple
possible explanations for these results: (1) When iron is present in abundance, as it is in cell
culture media, some metallation of PHDs could proceed in a PCBP-independent manner;
(2)PHD activity may be present in excess in vivo, and large decreases in PHD activity may
be required before HIF1α hydroxylation decreases and HIF1α accumulation occurs; (3)
PCBPs may be required for the remetallation of PHDs when the active site iron is lost, and
iron limitation with DFO could accelerate the turnover of iron in PHD active sites. The
sensitivity of PHDs to DFO treatment in vivo would suggest that the active site iron is readily
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exchangeable with available cytosolic iron pools. The loss of PHD activity in lysates lacking
PCBP1 or 2 may reflect a role for PCBPs in maintaining iron in the active site in vitro, as
well.
Our data do not suggest, however, that PCBP1 and 2 can functionally substitute for
each other. Cells lacking PCBP1 or 2 contain wild-type levels of the other paralog.
Furthermore, while addition of purified, iron-loaded PCBP1 to lysates lacking PCBP1 fully
restored PHD activity, addition of PCBP1 did not restore activity to lysates lacking only
PCBP2. PCBP1and 2 may function as a hetero-oligomeric complex to deliver iron to targets
such as ferritin and PHD. PCBP1 and 2 bind to each other when in complex with mRNA
(Makeyev and Liebhaber, 2002), and we have confirmed this interaction. Our data suggest
a model in which PCBP1, in complex with PCBP2 or another PCBP family member, binds
iron and interacts with target nonheme iron enzymes to donate metal to the active site. The
differences in HIF1α accumulation that occurred with depletion of PCBP1 versus 2 may
reflect the activity of PCBP1 in complex with residual PCBP2 or with PCBP3 or PCBP4,
which are expressed at low levels in cells.
Our studies indicate that ferritin, PHD, and FIH1 receive iron from PCBPs. Ferritin and
the

2-OG

dependent

hydroxylases

are

structurally

dissimilar,

but

have

certain

characteristics in common that may point to mechanisms of iron donation. Both ferritin and
PHD2 can bind iron after folding into their native conformations. Thus, PCBPs could interact
with these targets posttranslationally to donate iron. The H-chain of ferritin catalyzes the
oxidation of Fe(II) to Fe(III) for ferritin core mineralization, and the ferroxidase center
structurally and mechanistically resembles the catalytic centers of the oxo-bridged diiron
family of monooxygenases (Crichton, 2009; Hintze and Theil, 2006). However, PCBP1 likely
does not provide iron directly to the ferroxidase sites of ferritin, as these sites are located on
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the interior surface of the ferritin sphere. Iron ions gain access to the ferroxidase sites
through pores lined with hydrophilic residues. PCBP1 could donate Fe(II) to the His, Asp,
and Glu residues that line these funnel-shaped channels. The active site of PHD2 and other
enzymes of this class is solvent-exposed and coordinates a single Fe(II) through a His-XaaAsp/Glu-Xaa(n)-His triad located deep in the active site pocket (Loenarz and Schofield,
2008; Ozer and Bruick, 2007). Thus, the iron ligands and the coordination environment in
these two enzymes are similar.
Given that PCBP1 serves as an iron chaperone for these two diverse target enzymes,
we suggest that it is highly likely that other enzymes of the Fe(II)- and 2-OG oxygenase
class will require PCBPs for metallation. Sequence analysis of the human genome indicates
the presence of more than 60 enzymes of this class, many of which have not been
functionally characterized, but are predicted to oxidatively modify a broad range of
substrates (Loenarz and Schofield, 2008; Ozer and Bruick, 2007). In addition to its role in
HIF regulation, FIH functions in mice as a regulator of metabolism, likely by hydroxylating
asparagine residues on proteins other than HIF (Zhang et al., 2010). This class also
includes the collagen prolyl and lysyl hydroxylases, mutations in which cause connective
tissue diseases in humans. A subclass of the 2-OG oxygenase family is defined by the
presence of the jumonji C domain and members of this subclass catalyze the oxidative
demethylation of mono-, di-, and trimethylated lysine residues located in histone proteins.
Another subclass of this family resembles the AlkB demethylase of E. coli. Eight members
of this subclass have been identified in humans, with activities that include the dealkylation
and oxidative demethylation of modified bases in both DNA and RNA.
PCBPs may act as iron chaperones for the diiron monooxygenases as well as the 2-OG
dependent dioxygenases and represent the major distributors of iron for the metallation of
cytosolic nonheme iron enzymes. The mechanism by which PCBPs acquire cytosolic iron is
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unknown. In yeast, cytosolic monothiol glutaredoxins are required to make iron available to
iron-requiring enzymes (Mühlenhoff et al., 2010). Whether PCBPs interact with these
glutaredoxins awaits further study.
5.5 Experimental Procedures
5.5.1 Cell Culture
Huh7, A549, HEK293, and HEK293T cells were grown in high glucose Dulbecco's
modified Eagle's medium with 10% fetal bovine serum, penicillin G, 50 U/ml, and
streptomycin, 50 µg/ml (Gibco-BRL).
5.5.2 Protein Depletion by siRNA
PCBP1 and 2 were depleted using Stealth Select RNAi (Invitrogen, sequences in Table
S5.1). A nontargeting, scrambled sequence siRNA pool was used as a control. Cells were
transfected with 50 pmol of siRNA and harvested at 3 days after transfection. For some
experiments, two sequential transfections spaced 24 hr apart were performed.
5.5.3 RNA Extraction and RT PCR
RNA was isolated from cells using the RNeasy RNA Isolation kit (QIAGEN). For
reverse transcription, 1 µg of total RNA was used in a reaction mixture containing dNTPs
and superscript II (Invitrogen). Reverse transcription was performed for 10 min at 25°C, 60
min at 42°C, and 5 min at 70°C. Quantitative real-time PCR was performed using SYBR
Green on an ABI 7500 system according to the manufacturer's protocols (primers in Table
S5.2). The HIF1α, FIH1, and PHD2 values were normalized to β-actin according to Pfaffl's
mathematical model for relative quantification in real-time PCR (Pfaffl, 2001). Actin
quantitation did not vary with siRNA or DFO treatment.
5.5.4 Immunoblot Analysis
Nuclear and cytoplasmic extracts were prepared using a nuclear extract kit (Active
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Motif). Nuclear extracts were used for HIF and CREB western blots. Membranes were
probed using mouse anti-HIF1α (Transduction, 1:1000) or mouse anti-CREB (Cell
Signaling, 1:1000) antibodies. For detection of hydroxylated HIF1α, A549 cells were treated
with 100 µM MG132 for 6 hr followed by 25 µM DFO for 2 hr. Nuclear extracts (40 µg) were
analyzed by western blotting with a rabbit antibody that specifically recognizes HIF1α
hydroxylation at proline 564 (gift of O. Aprelikova). Whole-cell lysates or cytoplasmic
extracts were used for all other western blotting experiments. Whole-cell extracts were
prepared by lysis with buffer A (25 mM Tris [pH 8]; 40 mM KCl; 1% Non-idet P40; 0.1%
Triton; 1 mM DTT; 1× protease inhibitor cocktail, Roche). Membranes were incubated with
the indicated primary antibodies, followed by detection with horseradish peroxidase-linked
secondary antibodies (Amer-sham) and enhanced chemiluminescence substrates (Pierce).
Antibodies used for western blotting were rabbit anti-PHD2 and anti-FIH1 (Novus
Biologicals), mouse antiPCBP2 (Novus Biologicals), mouse anti-HA (Covance), and
horseradish

peroxidase-conjugated,

mouse

anti-FLAG

(Sigma).

Antibody

against

recombinant human PCBP1 (Shi et al., 2008) was raised in chickens and purified from yolks
by the manufacturer (Covance) and used at 1:2000–1:5000. Western blots were quantitated
using ImageJ.
5.5.5 Luciferase Activity Assays
HeLa 3XHRE Luc cells (Tian et al., 1997) were cultured and PCBP1 and/or PCBP2
were depleted as described above. Firefly luciferase activity was assayed using DualLuciferase reporter system (Promega). Samples were read in Lumat LB 9507 luminometer
(Berthold Technologies). For FIH activity, PCBPs were depleted in HEK293 cells, then
plasmids encoding the GalDBD/HIF2α CADs, G5E1b-Luc reporter, pcDNA3.1-FIH1-mycHisA, and pRL-TK (Lando et al., 2002b) were transfected for 18 hr prior to measurement of
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luciferase activity. Activity was reported as the ratio to renilla luciferase control.
5.5.6 HIF Half-Life Determination
Huh7 cells depleted of PCBP1 and 2 were treated with 25 µM DFO for 2 hr.
Cycloheximide was added at 60 µg/ml, and the cells were collected at intervals. HIF1α was
analyzed in nuclear extracts.
5.5.7 VHL Capture Assay
HEK293T cells were depleted of PCBP1 and 2, treated with 25 µM DFO for 2 hr, then
lysed by sonication. HA-pVHL was synthesized by in vitro transcription/translation reactions
using TNT T7 Quick Coupled Rabbit Reticulocyte Lysate kit (Promega). The VHL capture
assay was performed as described (Aprelikova et al., 2009; Tuckerman et al., 2004) in
buffer containing 2-OG, ascorbate, and FeCl2.
5.5.8 PHD2 Assays
Biotinylated peptides derived from the HIF1α oxygen-dependent degradation domain
(Biotin-Acp-DLDLEALAPYIPADDDFQL

or

a

hydroxylated

control

Biotin-Acp-

DLDLEALAP[OH]YIPADDDFQL) were immobilized on NeutrAvidin-coated 96-well plates.
A549 cells were depleted of PCBP1 and/or 2, then harvested and resuspended in 1 ml
hypotonic buffer (20 mM HEPES, 5 mM NaF, 10 mM Na2MoO4 or Na3VO4, 0.1 mM EDTA,
protease inhibitor cocktail, and 2 mM DTT) for 15–20 min, then 0.5% NP-40 was added,
and the samples were vortexed for 10 s. Clarified lysates (50 µg/well) were incubated in
reaction buffer containing 20 mM Tris-Cl (pH 7.5), 5 mM KCl, 1.5 mM MgCl2, 2 mM DTT, 0–
100 µM ferrous sulfate, 0.5 mM 2-OG and 1 mM ascorbate for 45 min at room temperature.
Purified recombinant PCBP1 or albumin (30 µM) was loaded with 100 µM ferrous sulfate for
2 hr at 4°C in an anoxic chamber (Coy Laboratory Products), then added to lysates at a
final concentration of 3 µM protein/10 µM Fe(II). Peptide hydroxylation was detected using a
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polyclonal rabbit antibody raised against a hydroxylated HIF peptide, followed by addition of
a goat anti-rabbit HRP-conjugated secondary antibody (Santa Cruz). Luminescence was
measured in an EnVision plate reader (PerkinElmer).
5.5.9 Protein Purification
Human PCBP1 was cloned into a pCDF-sumo fusion construct vector (courtesy of Zhe
Yang) and transformed into BL21* Escherichia coli competent cells containing streptomycin
resistance. Cells were grown in LB media at 37°C to an OD600 of 0.6, induced with a IPTG
concentration of 0.1 mM and then grown for 22 hr at 15°C. Cells were collected,
resuspended in 30 ml of buffer A (20 mM Tris [pH 7.9], 250 mM NaCl, 30 mM imidazole,
20% glycerol, and 2.5 mM TCEP) with an EDTA-free protease inhibitor cocktail tablet
(Roche), 30 mgs of lysozyme, and were broken using a French Press. The extract was
spun at 21,000 rpm for 30 min and loaded on a nickel column. Separation was carried out
using a gradient between buffer A and buffer B (20mM Tris [pH 7.9], 250 mM NaCl, 500 mM
imidazole, 20% glycerol, 2.5 mM TCEP), with the protein eluting at 110–230 mM imidazole.
The sumo tag was cleaved by adding 1/1000 concentration sumo protease and incubating
overnight at 4°C. Protein was buffer exchanged with buffer A before passing on the nickel
column again to separate the tag from the untagged protein. The protein was run on a S200 gel filtration column (GE Healthcare) eluting at a molecular weight of ~75 kDa,
consistent with a protein as a dimer.
5.5.10 Immunoprecipitation
HEK293T cells were depleted of PCBPs, transiently transfected with p3xFLAG-CMVPHD2 (1 µg), then labeled overnight with 2 µM of
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Fe(II):NTA (1:4 molar ratio). The cells

were lysed in 50 mM Tris-HCl, (pH 7.5); 150 mM NaCl; 0.5% NP-40; and protease (Sigma)
and phosphatase inhibitors (Pierce). PHD2 was immunoprecipitated with anti-FLAG
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antibody and protein A dynabeads (Invitrogen). IPs from mock-transfected cells were used
to measure nonspecific
measured

by

55

Fe background. Beads were washed, and retained

scintillation

counting

(LS

6500,

Beckman

55

Fe was

Coulter).

For

coimmunoprecipitations, anti-PCBP1 antibody or bulk chicken IgY (Gallus Immunotech) was
coupled to magnetic M280 tosylactivated dynabeads (Invitrogen) using 100 µg of antibody.
Beads were then blocked in 0.5% BSA and washed with PBS (pH 7.4) containing 0.1% BSA
prior to use. Cells were treated 2 hr or overnight with either 20 µM ferric chloride or 100 µM
DFO. The cells were lysed in buffer A and lysates (3 mg) were incubated with beads,
washed, and the immune complexes were analyzed by western blotting.
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5.6 Supplementary Material

Figure S5.1 Depletion of PCBP mRNA by siRNA and Effects of Alternative siRNAs
(A) Huh7 cells were depleted of PCBPs as in Figure 1. Cellular mRNA was isolated and TPCR for PCBP1 and PCBP2 performed. Transcript levels were normalized to actin and
expressed as a percentage of the transcript detected in control siRNA-treated cells.
Numeric values for depleted PCBPs are indicated above the bars. RT-PCR was performed
in triplicate and the experiment repeated three times. Error bars indicate SEM. (B) Western
blot and quantification from cells treated as in A. PCBP1 was detected with a fluorescently
tagged secondary antibody and measured using the Odyssey Imaging system. (C) Huh7
cells were treated with 100 M DFO for the indicated times, then nuclear extracts were
prepared and subjected to Western blotting for HIF1. (D) HEK293T cells were transfected
with PCBP siRNAs. After 2 days cells were transfected with pmPCBP1, a plasmid carrying
silent mutations in human PCBP1 that prevent targeting by siRNA (Shi et al. 2008). (E)
Huh7 cells were transfected with PCBP siRNAs of alternative sequence. After 3 days cells
were treated with 100 M DFO for 2 hr, then nuclear extracts were prepared and subjected
to Western blotting for HIF1 and CREB. (F) Huh7 cells were subjected to 2 sequential
transfections, spaced 24 hr apart, with PCBP siRNAs of alternative sequence. After 3
days, nuclear extracts were prepared and subjected to Western blotting as in (E).
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Figure S5.2 Accumulation of HIF1 in A549 Cells Lacking PCBPs, Quantitation of VHL
Capture, and Depletion of PCBP mRNA in A549 and HEK293T Cells (A) A549 cells
were depleted of PCBP1 and PCBP2 by either single (left panel) or two sequential
transfections (right panel) of siRNA then treated with 100 M DFO for the indicated times.
Nuclear extracts were probed for HIF1 then stripped an reprobed for CREB and/or tubulin.
(B) A549 cells were treated with 25 M DFO for 2 hrs in the presence or absence of MG132.
Nuclear extracts were probed for OH-HIF1 and CREB. (C) A549 cells were depleted of
PCBPs as in Figure 3. Cellular mRNA was isolated and RT-PCR for PCBP1 and PCBP2
performed. Transcript levels were normalized to actin and expressed as a percentage of
the transcript detected in control siRNA-treated cells. (D) Western blot and quantification of
PCBP1 for A549 cells treated as in (C). PCBP1 was detected with a fluorescently tagged
secondary antibody and measured using the Odyssey Imaging system. (E) Western blots
of pVHL shown in Figure 3C were quantified and expressed as a percentage of control
siRNA-treated cells. Experiments were replicated twice or thrice and the mean +/- SEM is
shown. (F) RT-PCR from HEK 293T cells. Numeric values for depleted PCBPs are
indicated above the bars. RT-PCR was performed in triplicate and the experiment repeated
twice. Error bars indicate SEM.
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Figure S5.3 Reduced Efficiency of PCBP1 Depletion when PCBP2 Depleted
Simultaneously HEK 293T cells were depleted of PCBPs by 2 sequential siRNA
transfections. Extracts were subjected to Western blotting for PCBP1 and bands were
quantitated using Image J. PCBP1 remaining after siRNA treatment is indicated
numerically above the bar.

Figure S5.4 HEK 293T cells were treated overnight with 100 µM DFO. Cells were lysed
and PHD activity measured in the presence of increasing amounts of Fe(II). NC – negative
control, no lysate added. Assays were performed in triplicate, error bars indicate SEM.
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Figure S5.5 Depletion of PCBP mRNA in HEK293 Cells, Relative Abundance of PHD2
and FIH1, and Detection of FIH1 in Lysates and by Coimmunoprecipitation (A)
HEK293 cells were treated with siRNA as in Figure 7A. After 3 days, mRNA was isolated
and RT-PCR for PCBP1 and PCBP2 performed. Transcript levels were normalized to actin
and expressed as a percentage of the transcript detected in control siRNA-treated cells.
Numeric values for depleted PCBPs are indicated above the bars. (B) Levels of PHD2 and
FIH1 mRNA in Huh7, A549, and HEK293T cells measured using RT-PCR. Cells were not
transfected or treated with DFO. RT-PCR was performed in triplicate. Error bars indicate
SEM. (C) Detection of FIH1 by Western blot in HEK293 cells transiently transfected with
plasmid pFIH1 (left panel), in untransfected cells (center panel), and HEK293 cells
transiently transfected with pFIH1 (right panel). FIH1 is detected as a single species or as a
doublet in both transfected and untransfected cells. (D) Co-immunoprecipitation of FIH1
with PCBP1. Co-immunoprecipitation was performed in HEK293 cells with and without
transient transfection as in Figure 5.7.
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Table S5.1 PCBP1 and PCBP2 siRNA Sequences

Table S5.2 Primers Used for RT-PCR
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CHAPTER 6
SUMMARY AND FUTURE DIRECTIONS
6.0 Prelude
The importance of ferritin in maintaining iron homeostasis is well established (1). Even
when our iron consumption does not compensate the body's iron loss, we maintain
appropriate levels of available iron due to the function of ferritin. Ferritin functions as a
"buffer" against iron deficiency (if the blood has too little iron, more can be obtained from
ferritin) and, to a lesser extent, iron overload (if the blood and tissues of the body have too
much iron, ferritin stores the excess) (2). The unique capacity of ferritin to conserve the
body from both iron deficiency and iron overload makes its role in maintaining cellular iron
homeostasis very significant. A major component of this process is the proper delivery of
iron to ferritin for storage, and the role of PCBPs in doing so. A comprehensive in vivo and
in vitro characterization of these iron chaperone proteins, the PCBP protein family, has
been carried out for the first time and presented here in this dissertation. This work is
entirely novel in the sense that there are only 2 papers published on this topic so far. Thus
we believe this work will lay the foundation for future experiments aimed at unfolding the
exact mechanistic details of iron delivery to ferritin by the PCBP chaperones. This work will
help elucidate key events that lead to iron uptake/absorption in the body and in the general
regulation of iron homeostasis in humans and lead to improved treatment strategies for
disorders related to a cellular iron imbalance.
The first part of this chapter summarizes results obtained so far that are described in
detail in chapters 2 to 5 of this dissertation. The section ‘Future Directions’ is aimed at
discussing some of the potential directions in which the project can proceed. These
experiments have already been initiated and can serve as interesting starting points to a
new graduate student taking over the project.
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6.1 Summary
6.1.1 The initial discovery of PCBP’s as iron chaperones
Dr. Caroline Philpott of NIH made the initial discovery of PCBP1 as an iron chaperone
to ferritin. These findings were published in Science with the following reference: Heifeng,
S. et al. A cytosolic iron chaperone that delivers iron to ferritin. Science. 2008 May 30;
320(5880): 1207-1210. A genetic screen was designed to identify human genes that could
increase the amount of iron incorporated into human ferritin when expressed in yeast cells,
which do not themselves express ferritin. PCBP1 was able to increase the amount of iron
loaded into ferritin by 2.3 fold when co-expressed in yeast cells. When PCBP1 was depleted
in cultured human cells, it resulted in an increase in the labile iron pool, which led to an
increase in the iron-mediated degradation of iron-regulatory protein 2. On the contrary, the
amount of iron loaded into ferritin decreased. Ferritin immunoprecipitated in a complex with
PCBP1 only in buffers containing ferrous iron. Using isothermal titration calorimetry, purified
human PCBP1 was found to bind ferrous iron in a 3 Fe: 1 PCBP1 ratio with an affinity of 0.9
– 5.8 µM. Purified PCBP1 increased the incorporation of iron into apo-ferritin in vitro,
indicating that PCBP1 could directly bind and donate iron to ferritin.
6.1.2 In vivo evidence that all the four PCBPs are iron chaperones to ferritin
Following the initial discovery of PCBP1 as an iron chaperone (3), an immediate
question that followed was whether the other three family members would be involved in
iron delivery to ferritin. The answer is ‘yes’. Chapter 4 discusses the evidence in support of
this statement. In brief, PCBP2 is also an iron chaperone for ferritin since expression of
PCBP2 in yeast expressing human H and L ferritin activated the iron deficiency response
and led to increased iron deposition into ferritin. Depletion of PCBP2 in Huh7 cells led to
diminished

iron

incorporation

into

ferritin.

Both

PCBP1

and

PCBP2

were

coimmunoprecipitated with ferritin in HEK293 cells and both PCBPs exhibited micromolar
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binding affinity for Fe(II) and for ferritin in the presence of iron. Nevertheless, PCBP1 and
PCBP2 have independent, non-redundant functions as iron chaperones. Evidence
presented in this chapter also indicates that the two proteins PCBP1 and PCBP2 work as a
complex to deliver iron to ferritin.
In yeast cells, PCBP3 was able to activate the iron deficiency response and to load iron
into ferritin, similar to the capabilities of PCBP1 and PCBP2. In human cells, a direct binding
between PCBP3 and ferritin was demonstrated. A splice variant of PCBP3 (PCBP3.2) was
identified, that showed reduced capacity to activate the iron deficiency response and to load
iron into ferritin but could still retain ferritin-binding activity. These data suggest that PCBP3
is a cellular iron-binding protein and could function as a chaperone. The fourth family
member PCBP4 is functionally dissimilar to the other PCBPs. PCBP4 showed only weak
genetic and physical interactions with ferritin. However, its ability to activate the iron
deficiency response in yeast suggested iron-binding capability. The difference in their
functionality became clear while experimenting with a yeast strain that are sensitive to iron
toxicity. Under normal conditions, neither PCBP1 nor PCBP4 had any effect on the growth
of the strain. But under high levels of iron that are toxic to the strain, PCBP1 enhanced the
toxicity while PCBP4 protected cells from the toxic effects of iron. Thus, all PCBP family
members have iron chaperone activity, although PCBP4 exhibits reduced interaction with
ferritin.
6.1.3 In vitro characterization of iron binding abilities of PCBP1, PCBP2 and PCBP3
Following the in vivo experiments that identified the PCBPs are iron chaperones, we
wanted to understand the structural properties of the binding interactions. For this, we
performed a comprehensive in vitro characterization of the metal binding properties of three
of the PCBP family members (PCBP1, PCBP2 and PCBP3), which are elaborated in
chapters 2 and 3. Experiments were performed specifically to provide a basic
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characterization of the biophysical properties of PCBPs 1, 2 and 3 before metal loading and
to characterize the metal binding ability, structure and electronic properties of metal bound
to the proteins. Cloning and expression tests were followed by protein purification
techniques to obtain mM concentrations of pure protein. Basic characterizational
experiments included using mass spectrometry to confirm the molecular weight of the
proteins, size exclusion chromatography to obtain protein oligomeric state and circular
dichroism experiments to compare the secondary structure of the three proteins. Metal
binding characteristics were investigated using isothermal titration calorimetry (ITC), X-ray
absorption spectroscopy (XAS) and Mossbauer spectroscopy techniques. Combined, these
studies help clarify the molecular picture of how the PCBP’s can participate in metal transfer
to ferritin.
6.1.4 Ability of PCBPs to deliver iron to prolyl hrdroxylase
Apart from ferritin, we identified PCBP 1 and 2 as being capable of delivering iron to
another enzyme, prolyl hydroxylase domain 2 (PHD2), which regulates hypoxia inducible
factor 1 α (HIF1α) (4). These studies were discussed in chapter 5. siRNA knockdown of
PCBP1 or PCBP2 in mammalian cells resulted in reduced PHD activity. In cells depleted of
either protein, there was almost complete loss of PHD activity, which could be fully restored
with high concentrations of iron. This indicated that the loss of PHD activity was due to the
loss of iron incorporation into PHD, in turn, caused by the absence of PCBPs 1 or 2. These
studies also indicated that both PCBP1 and PCBP2 were necessary for PHD activity but
their roles were non-redundant. Their non-redundant roles was confirmed by addition of
PCBP1-Fe(II) complex to cells lacking either PCBP1 or PCBP2. While the PCBP1-Fe(II)
complex was able to restore activity of PHD in cells lacking PCBP1, the complex had no
effect in cells lacking PCBP2. Another protein similar to the PHDs is Factor inhibiting HIF 1
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(FIH1), an asparagyl hydroxylase involved in the oxygen- and iron-dependent regulation of
HIF1α (5-7). In cells lacking PCBP1, there was reduced FIH1 activity due to a reduction in
the iron incorporation of FIH1. Thus the iron chaperone activity of PCBP1 and PCBP2 is
involved in the metallation of at least two members of this enzyme family and there could be
more (8).
6.2 Future Directions
The iron chaperone field is in its infancy, with many more questions unanswered than
resolved. This largely increases the scope of what can be done in this field. There are a
number of interesting questions that can be pursued. Work in a few directions has already
begun and the preliminary results obtained have been summarized below.
6.2.1 Biophysical characterization of PCBP4
As stated earlier, PCBP4 may bind iron, but it is functionally different from the other
PCBPs in that it exhibits a reduced interaction with ferritin. To help clarify the iron binding
abilities of PCBP4, and to better understand its role in ferritin iron loading, an in vitro
characterization of the protein’s iron binding abilities, as has been carried out for the other
family members, would be very useful. Work in this direction has already begun. Human
PCBP4 was cloned into two different vectors, pTYB11 (from NEB) and pESUMO (Life
Sensors). An expression test was carried out with the pTYB11 system in which 3 ml of TB
culture was inoculated with a freshly transformed colony. The culture was shaken at 37 °C
until an OD600 of 2.0 was reached and then induced with 0.4 mM IPTG and grown for 22 h
at 16 °C after induction. Cells were spun down at maximum speed on a tabletop centrifuge
and lysed using a sonicator. Both uninduced and induced samples were run on a gel for
comparison. The fusion construct expressed at ~ 95 kDa (PCBP4+intein tag) as visualized
on an SDS-PAGE gel in Figure 6.1. After successful expression of the construct, we
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Figure 6.1 Expression test and purification of PCBP4-pTYB11. (A) SDS-PAGE gel of
pTYB11-PCBP4 expression test. Shown within the red box is the expression of
PCBP4+intein tag in the induced samples as compared to the uninduced samples. C- Cell
lysate (whole), S-soluble, P-pelette. (B) SDS-PAGE gel of purified PCBP4 fractions using
the intein system. Shown within the red box are PCBP4 elution fractions at c.a 40 kDa
after self-cleavage of intein tag.
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proceeded to purify the protein according to previously established protocols (Chapter 3).
Unfortunately, as can be seen in Figure 6.2B, there was low amount of purified protein, and
the purity of the eluted fractions was also low. This protein was neither concentrated
enough nor pure enough for the desired spectroscopic characterization experiments. A
direction to proceed would be to test the expression and purification of PCBP4 with the
pESUMO system, with which we have had much success in the past. The construct of
pESUMO-PCBP4 has already been cloned and available as a starting point for further
expression tests. Once mM quantities of pure protein are obtained, biophysical
characterization of the protein can be carried out as described in chapters 2 and 3 of this
dissertation.
6.2.2 Can PCBPs bind other metal ions such as Zinc?
Gel shift experiments from our collaborator, Dr. Caroline Philpott, have shown some
interesting results (unpublished data) regarding metal binding. During an attempt to look at
the effect of different metals on the binding of a DNA oligonucleotide to the PCBPs, it was
discovered that zinc specifically inhibits the binding of DNA with a Ki in the low micromolar
range. Given the high concentration of cellular zinc, we believe zinc binding may also
contribute to the story for this protein. An ITC experiment was carried out in 50 mM Tris, 200
mM NaCl (pH-7.6) to measure zinc binding thermodynamics. Titration of 1 mM zinc into
solutions of 25 µM PCBP2 at 30 °C under anaerobic conditions produced negative peaks in
the raw thermogram, which indicated zinc bound PCBP2 in an exothermic process. An
integration of each individual titration peak gave rise to the processed spectrum (Figure 6.2).
Zinc binds PCBP2 with micromolar binding affinity.
The fitting analysis showed that PCBP2 bound 2.08 ± 0.054 Zn atoms with the binding
affinity of 9.0 ± 6.6 µM. Metal binding event was enthalpically favorable (ΔH=-8.6 Kcal/mol)
and entropically unfavorable (ΔS=-5.81 cal/mol) with overall favorable free energy ΔG=-8.61
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Figure 6.2 ITC of Zn and PCBP2 showed PCBP2 bound 2 atoms of Zn

151
Kcal/mol. Further experiments are needed to confirm the ability of PCBP2 to bind zinc and
to test if the other PCBPs are also involved in zinc binding. Further, ITC can be used to test
biologically and biochemically important metals (such as Mn(II), Co(II) and Tb(III)) for their
binding affinities to the PCBPs. Quantitatively, this will give us an understanding of how
tightly PCBPs bind Fe as compared to other metals. Qualitatively, this will lay the foundation
for further investigation and research in the field of possible other metallochaperone metal
binding interactions.
6.2.3 Determination of metal binding sites by NMR
To our knowledge, there is no known data so far on the active site residues of PCBPs
involved in iron binding. This finding will fill a fundamental gap in our understanding of how
these iron chaperones bind iron and deliver it to ferritin, and how each residue helps define
the metal binding site. In order to answer this question, NMR can be used. The Stemmler
lab has successfully used this method in the past to determine the metal binding residues
on the protein Yfh1 as described in (9). As the apo NMR structure of PCBP2 domains is
known (10), it is possible to compare the
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N-filtered HSQC spectra of both and from this

identify the amide chemical shift perturbations of residues affected by the presence of iron.
Thus it is possible to identify the metal binding residues on the proteins. The NMR structure
of the first two domains of apo-PCBP2 is displayed in Figure 6.3 (10). Since the chemical
shifts for the apo protein have been determined, we can collect an
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N-filtered HSQC

spectrum of the two domains in the presence of iron, then we can compare it to the apo
spectrum to identify the metal binding residues in the first two domains. To initiate this, we
created a clone of the first two domains of PCBP2 (residues 11-169) in a pSUMO vector
from Lucigen. An expression test was carried out by growing cells at 37 °C for 4h after
induction with 0.1 mM IPTG (Figure 6.4). From the gel, it is clear that the protein expresses
in the soluble fraction, which can be used for further purification.
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Figure 6.3 NMR structure of first 2 domains of PCBP2

Figure 6.4 SDS-PAGE gel showing expression of KH1-KH2 domains at 27 kDa.

153
This project can be immediately pursued since the construct has been created and the
expression conditions have been determined. It would be required to grow the cells in
labeled media and then collect an

15

15

N

N-filtered HSQC spectrum of the construct in the

presence of iron. This would then be compared with the published apo structure to
determine the metal binding residues. This data would provide a significant advancement in
the PCBP project.
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Biological Role of Ferritin - Iron is essential for life and often utilized as a cofactor in many
proteins. In humans, iron accumulation causes cirrhosis, arthritis, cardiomyopathy and
diabetes mellitus, and it is associated with increased risk of cancer and heart disease. In
contrast, decreased brain iron content results in permanent neurocognitive and motor
impairment. Intracellular iron content must be maintained within a narrow range to avoid
the adverse effects of iron depletion or excess, and this function is performed by the protein
ferritin. Ferritins are iron storage proteins that are ubiquitously expressed in animals, plants
and bacteria. They serve both to sequester excess iron taken up by the cell and to release
stored iron to meet the cell’s metabolic needs during iron scarcity. Ferritin’s capacity to store
iron is therefore essential for life.
PCBP1 is an iron chaperone for ferritin - Our work shows that human Poly r(C)-Binding
Protein family are essential for ferritin iron loading. In vivo, depletion of PCBP1 inhibits
ferritin loading and increases cytosolic iron pools. In vitro, PCBPs binds iron with an affinity
similar to other iron chaperones.

Based on these data, we believe the PCBPs are

functional iron chaperones that deliver iron to ferritin, hence promoting maintenance of
cellular iron homeostasis. Our objective was to characterize the molecular details of the
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interaction between PCBPs, iron and ferritin using biophysical tools such as X-ray
absorption spectroscopy, Mossbauer spectroscopy and Isothermal Titration Calorimetry.
This work will help elucidate key events that lead to iron uptake/absorption in the body and
in the general regulation of iron homeostasis in humans. It will also lead to improved
treatment strategies for disorders related to cellular iron imbalance and heart disease.
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